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Calorie restriction (CR) has long been heralded as the only proven 
nutritional intervention for life extension.  Recent data demonstrated that 
moderate CR also extended reproductive lifespan in female rats.  The objectives 
of this project were to: 1) analyze general hormonal changes that occur with 
aging and menopause and 2) evaluate the effects (whether beneficial or 
detrimental) of moderate (30%) CR on ovarian function and decline in rhesus 
monkeys (Macaca mulatta).  
Hormone analyses demonstrated elevated FSH and reduced INHB in Old 
monkeys, prior to menstrual cycle irregularity and alterations in E2 or P4.  Our 
data are the first demonstration of this hormonal event occurring in monkeys.  
Furthermore, moderate CR did not impair normal ovarian function or aging. 
Evaluation of three clinically available tests: day 3 FSH, the Clomiphene 
Citrate Challenge Test (CCCT) and the Exogenous FSH Ovarian Reserve Test 
(EFORT), demonstrated that CCCT is efficacious in monkeys, especially with the 
use of E2 and INHB. As such, CCCT is the most cost effective and best predictor 
of ovarian response.  Responses were similar between CON and CR. 
Oocytes from old short-term CON and CR monkeys were collected and 
fertilized with spermatozoa collected from normal males.  Interestingly, CR 
appears to prolong ovarian responsiveness to exogenous gonadotropins and 
improve embryonic development in vitro in old female rhesus monkeys.  
Microarray analysis of gene expression was conducted in luteinizing 
granulosa cells.  A subset of responsive genes were identified that will require 
validation by via real time polymerase chain reaction (RT-PCR).  These data will 
provide insight into potential mechanisms of direct action of CR on the ovary. 
Therefore, the results of this study have provided evidence for the utility of 
the rhesus monkey as a model for human menopause.  Additionally, moderate 
CR did not impair normal reproductive function or decline.  We also confirmed 
the efficacy of the CCCT in rhesus monkeys and recommend its use as a 
diagnostic tool.  Finally, CR improved ovarian response to exogenous 
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The average age of menopause in women is approximately 51 years, 
resulting in a post-reproductive period that extends for nearly one third of their 
lives (Treloar, 1981).  Further, because many women have elected to delay 
reproduction, due to career and other considerations, they have encountered the 
reality of reproductive aging and ovarian aging.  Consequently, the mechanisms 
involved in the processes of ovarian aging have gained increased visibility and 
relevance.  The hypothalamic-pituitary-gonadal axis (HPG) is central to 
reproductive function (Figure 1.1).  External cues, such as nutrition and stress 
can modify HPG function as well.   In the ovary, as follicles mature, various 
hormones contribute to the different stages of recruitment and selection.  The 
gonadotropins follicle-stimulating hormone (FSH) and luteinizing hormone (LH) 
have important roles in follicular development and ovulation and are regulated by 
the hypothalamus (via gonadotropin releasing hormone; GnRH), anterior pituitary 
gland and the ovary.  In terms of the ovarian hormonal milieu, estradiol and 
progesterone are major players and have been well characterized.  Additionally, 
the inhibins and activins have important roles in FSH regulation.  Furthermore, 
there are a number of growth factors that have paracrine and autocrine effects as 
well.   
The function of the HPG axis retains remarkable similarity across taxa.  A 
period of reproductive immaturity is followed by a period of reproductive maturity 
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and activity, finally ending with a period (variable in length) of reproductive 
senescence and loss of function.  Reproductive decline during aging is evident in 
nonhuman primates, domestic livestock, elephants, whales, and lions as just a 
few examples (Packer et al., 1998).  Evolutionary hypotheses seek to answer the 
question of why menopause occurs; cellular hypotheses attempt to answer the 
question of how it occurs; and research models create opportunities to study 
these questions in the laboratory.   
Historically, it has been believed that female vertebrates acquire 100% of 
their primordial follicles at or around the time of birth.  This doctrine has recently 
been brought into question by Johnson and colleagues (Johnson et al., 2004) 
who demonstrated that ovarian follicular renewal may be possible in mice.  
Regardless of the process, however, by menopause the ovary is almost 
completely devoid of follicles.  Throughout the reproductive lifespan of any 
female, the number of follicles that become atretic is much greater than the 
number of follicles that actually proceed through to ovulation.  Thus, ovarian 
aging in one form or another is a consistent theme.   
Chronological age is a useful, although not always accurate predictor of 
reproductive function and progression into peri-menopause.  Although in women, 
the final menopause does not occur until mid-life, the initial changes leading to 
the climacteric occur years before, in their late 20’s.  Modern demands from 
education and career often delay childbearing to those same years, creating 
potential issues with fertility and pregnancy success.  Therefore, useful 
diagnostics capable of evaluating ovarian function can save valuable time and 
 2
resources.  Despite competing theories regarding the mechanism of the loss of 
follicles coincident with ovarian decline, ultimately reduced ovarian reserve is a 
consistent theme.  Development of reliable methods with which researchers may 
predict the onset of, or assess the extent of ovarian decline would be extremely 
beneficial. 
   Furthermore, if menopause merely affected fertility, the study of ovarian 
aging would likely not be of such high priority.  A number of other physiological 
systems are also affected by the sudden withdrawal of hormonal support 
associated with menopause, including: bone density, cardiovascular health, 
cognition and possibly some cancers (Johnson et al., 2004; Nappi et al., 1999; 
Prior, 1998; Sherwin, 2003).  Given the wide range of physiological systems 
affected by menopause, the idea of delaying ovarian decline is attractive.  To 
date, there are no proven methods of extending reproductive lifespan in 
primates, however, it is currently under study. 
 
II. CURRENT HYPOTHESES ON OVARIAN AGING AND MENOPAUSE 
Evolutionary Hypotheses and Theories 
 In humans, women experience a dramatic loss in ovarian function and 
subsequent menopause around the age of 50 (Treloar, 1981).  Thus, with the 
average lifespan ~70-80 years, a woman will spend a significant portion of her 
life in a post-reproductive state.  It has been suggested that menopause is simply 
a non-adaptive by-product of increased longevity in humans, since it seems 
contrary to maximizing Darwinian fitness (Blurton Jones et al., 2002).  That is, 
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rapid advances in medicine, nutrition and health have allowed people to live 
much longer than they have in the past.  One hundred years ago the average life 
expectancy was about ~30-40 years, so there was likely little to no post-
reproductive life.  Some scientists believe that not enough time has passed for an 
evolutionary effect; therefore, menopause is little more than a side effect of 
increased lifespan.  Others have hypothesized that menopause evolved as 
“quality versus quantity” trade off.    
Table 1.1 summarizes the following hypotheses and theories.  Specifically, 
menopause may have evolved as a result of the rapid encephalization of humans 
in combination with acquisition of bipedal movement (Peccei, 2001; Williams, 
1957).  As humans became more adept at making and handling tools, brain size 
increased dramatically.  Increased brain size resulted in a more altricial infant 
(helpless, with an extended parental care requirement). Additionally, evolution of 
bipedal locomotion resulted in pelvic alterations that made delivery more 
dangerous and difficult.  It may be that as women aged, the mortality risk and 
energetic requirements of pregnancy, delivery and lactation became too great to 
risk.  The extreme altriciality of human infants requires a large parental 
investment.  Thus, the Good Mother Hypothesis (Alexander, 1974; Nesse and 
Williams, 1996; Sherman, 1998), states that there is a trade-off between 
increasing allelic contribution to the population (having more children) and 
ensuring the survival of present children.  The Grandmother Hypothesis (Blurton 
Jones et al., 2002; Gibbons, 1997; Hawkes et al., 1998) is an extension of this 
theory, but it more directly addresses the post-menopausal period.  It agrees with 
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the general risk of pregnancy at advanced ages, but also addresses the 
contribution of the grandmother to her grandchildren in assuring her own 
personal “fitness.”  That is, a re-allocation of her reproductive effort to care for 
children already born, as opposed to production of offspring unlikely to survive 
maternal death.  Although we usually think of this reproductive strategy in the 
context of humans and possibly non-human primates, elephants and pilot whales 
also show this type of social structure and have an extended period of post-
reproductive lifespan.  It is plausible that in some higher vertebrates, this strategy 
is useful in species that require extensive caretaking and energy investment 
during infant and maturing phases in the lifespan. 
In a more general sense, the Disposable Soma Theory of Aging 
(Kirkwood, 2002) is based on the supposition that organisms favor reproductive 
systems over systems responsible for maintenance and repair.  In other words, 
an animal will place the majority of its energy into reproductive development, and 
maintenance and aging occurs as a result of “neglected” systems.  An example 
of this theory may be found in the reproductive history in some laboratory mice 
that exhibit a systematic decline in function over time.  In the wild, however, the 
mouse’s reproductive ability may be perfectly functional up until its demise.  The 
main difference of course is that in the laboratory, the mouse is in a protected 
environment and may live well beyond the typical age of a mouse in the wild.  
Thus, the Disposable Soma Theory states that the mouse has devoted most of 
its energy into maintaining reproductive function, but would need to continue only 
as long as the animal is likely to survive.  Following cessation of reproduction, the 
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mouse deteriorates physiologically, as little energy has been delegated into 
maintenance of its somatic functions, ultimately resulting in many of the aging 
phenotypes observed in captivity.  Finally, it is clear in some species, such as 
mice, that animals showing an age-related deterioration in their “fitness” are likely 
to be predated; whereas, animals in the laboratory are likely to survive much 
longer.  This suggests that the aging phenotype observed in the laboratory would 
be rare in the wild, further supporting the validity of the Disposable Soma Theory.  
Like a protected captive animal, advances in human health and medicine have 
protected women and thus the rate of increase in lifespan may have exceeded 
the rate of increase in reproductive lifespan. 
 
Cellular Hypotheses 
Ovary-Driven Reproductive Aging 
The depletion of follicular reserve and subsequent loss of fertility provide 
one explanation for how menopause occurs (vom Saal et al., 1994).  It has 
historically been believed that the final population of oocytes in the adult female 
is established during a stage in embryogenesis where the primordial germs cells 
undergo a multitude of mitotic divisions and formation of oogonia (Wassarman, 
1994).  Cells enter meiotic prophase and remain arrested in the cell cycle as 
primary oocytes, until puberty and exposure to appropriate levels of 
gonadotropins.  During the peri-pubertal phase, development of gonadotropin-
dependent granulosa cells mediate oocyte growth.  Depending on the species, 
some preantral follicles are recruited, and one or more antral follicle(s) are 
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selected for ovulation.  At this point, the recruited oocyte awaits signals from the 
pituitary for ovulation and resumption of meiosis.  Follicular cells in the recruited 
oocytes undergo functional changes resulting in production of progesterone and 
preparation for fertilization.   
The prolonged cell cycle arrest just described is a unique feature of female 
vertebrate gonadal development.  Thus, the follicular or ovarian reserve provides 
an exhaustible resource of oocytes and follicles that is established at or around 
the time of birth.  Faddy et al. (Faddy et al., 1992) reported the age-related bi-
exponential decline in follicles; however, the accuracy of those data are 
debatable.  Arguments suggest the bi-exponential decline is an artifact of the log-
linear transformation and that follicle depletion is in fact monophasic (Leidy et al., 
1998).  In any event, the ovarian follicular reserve declines during aging and the 
majority of follicles are lost in atretic processes (Faddy et al., 1992; Johnson, 
2003).  It becomes very interesting to examine not only the fundamental biology 
of this process, but also the potential for extending ovarian function with 
interventions known to affect overall lifespan. 
Inhibin (INH) was first identified and characterized in 1932 and shown to 
be involved in the regulation of the pituitary gland.  It is a dimeric, glycoprotein 
hormone consisting of an α subunit with either a βA-- or βB- subunit, denoted as 
inhibin A (α -βA; INHA) or inhibin B (α -βB ; INHB; (Soules et al., 1998).  Using in 
situ hybridization, Roberts et al. (Roberts et al., 1993) localized the expression of 
the inhibin subunits in human ovaries throughout the menstrual cycle.  They 
determined that the α subunit  was expressed in the granulosa cells of small 
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antral as well as in dominant follicles.  Subsequent studies on circulating levels of 
inhibins throughout the menstrual cycles determined that INHB is the dominant 
inhibin produced in the early and mid-follicular phase, whereas INHA is the 
dominant inhibin synthesized in the late follicular and luteal phases (Groome et 
al., 1994; Groome et al., 1996).   
Interest in INH has become more prevalent with respect to reproductive 
aging and menopause as its association with follicle stimulating hormone (FSH) 
has become more defined.  Increased levels of FSH in older women are evident 
throughout the cycle; however, this elevation is most consistent in the early 
follicular phase.  It remains unclear whether rising FSH levels are directly due to 
lowered levels of inhibins.  Soules and colleagues (Soules et al., 1998) 
hypothesized that once the number of pre-antral follicles falls below some critical 
threshold, the subsequent drop in INHB may result in rising levels of FSH (Figure 
1). Welt and colleagues (Welt et al., 1999) compared daily menstrual cycle 
hormone levels in younger and older cycling women to characterize the 
relationship between the inhibins and the menopause-associated rise in FSH.  
They determined that INHB remained lower among older cycling women 
throughout the menstrual cycle, while estradiol-17β (E2) and FSH in the older 
women varied (either higher or lower than the young at specific times) as 
compared to FSH levels in younger cycling women. Therefore, FSH did not 
appear to be consistently predictive of an individual’s reproductive system status.  
Overall, these data confirmed an inverse relationship between INHB and FSH as 
well as a general decline in INHB, INHA and progesterone (P4) prior to 
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detectable differences in circulating Estradiol levels.  The decrease in INHB 
appears to be one of the earliest hormonal events that may lead to the age-
associated increase in FSH (Klein et al., 2004; Welt et al., 1999).  This lends 
credence to the hypothesis that reduced follicle numbers and consequently 
reduced INHB levels, lead to the monotropic rise in FSH observed in peri-
menopausal women.   
 Increased levels of FSH during reproductive aging have been documented 
across several species.  de Souza et al. (de Souza et al., 1998) demonstrated 
that endocrine changes occur with ovarian aging in sheep and that the pattern of 
change was similar to that observed in women.  Specifically, there were 
significantly fewer antral follicles available for development in older ewes during 
the early luteal phase, despite similar ovulation rates compared to their younger 
counterparts.  Consequently, INHA was reduced in both the follicular and luteal 
phases in older animals, and this was associated with increased concentrations 
of FSH during the luteal phase.  Estradiol levels, however, were similar between 
the two age groups.  These data are consistent with the view that there is an 
overall depletion of the follicular pool during the process of aging.  The 
maintenance of similar number of ovulations in older animals suggests that a 
greater proportion of the follicular pool in an aging female is promoted through to 
ovulation.  At some point, there appears to be insufficient number of developing 
follicles to produce the hormonal support necessary to stimulate hypothalamic 
GnRH and the subsequent preovulatory LH surge.  This diminished 
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responsiveness and coincident decline in ovarian function snowball, leading to 
eventual reproductive failure.   
 
Brain-Driven Reproductive Aging  
 There is evidence suggesting that the age-related increase in FSH levels 
ultimately leads to an accelerated follicular loss and subsequent ovarian failure.  
Changes that occur in the temporal pattern and synchrony of neurochemical and 
neuroendocrine signals may trigger the cascade of peri-menopausal events.  It 
has been suggested that miscommunication between the brain and the pituitary-
gonadal axis occurs as a result of dampening and desynchronization of neural 
signals (te Velde et al., 1998). 
 Meredith et al. (Meredith et al., 1992) researched the effect of unilateral 
ovariectomy (ULO) on the rate of loss of primordial follicles.  Young and middle-
aged rats were ovariectomized unilaterally and observed for changes in the loss 
of primordial follicles.  The investigators determined that ULO triggered an 
increased loss of follicles, but only in the old rats.  A subsequent study by 
Anzalone and colleagues (Anzalone et al., 2001) showed that ULO reduced 
follicular reserve in young and old rats.  The effects of ULO were then compared 
in young virgin and middle-aged (MA) breeder female rats relative to sham-
operated controls.  Results revealed that ULO reduced ovarian follicular reserve 
to levels similar to MA control rats.  Although preovulatory estradiol-17 β (E2) 
levels were found to be similar between groups, there was reduced follicular 
reserve and significantly lower amplitude in the LH surge on the evening of 
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proestrous.  Moreover, the reduction in the LH surge was correlated with 
numbers of resting follicles.  Interestingly, despite similar follicular reserves in the 
young ULO and MA control rats, MA rats still showed lower peak LH levels as 
well as fewer regular cycles.  Young ULO animals also had increased FSH levels 
on the morning of estrous (likely a compensatory response), while MA ULO rats 
did not.  This elevated FSH release in young ULO rats was associated with an 
increase in follicular development so that the number of preovulatory follicles in 
the single ovary of these animals was similar to the number of preovulatory 
follicles in both ovaries of the young controls.  Therefore, experimental reduction 
in ovarian reserve affected the LH surge, ovulation and cyclicity in both young 
and MA ULO animals.  However, young ULO females demonstrated a 
compensatory response by raising FSH levels despite reduced follicular reserve, 
suggesting a fundamental age-related alteration in the regulation of FSH 
unrelated to follicular reserve.   
Limited data are available suggesting an age-related alteration in the 
central LH surge mechanism in peri-menopausal women (Park et al., 2000).  
Estradiol challenge in young and peri-menopausal women showed the predicted 
transient decrease in LH and FSH levels, presumably associated with negative 
feedback at the level of the hypothalamus.  Following this initial decrease, 
however, seven out of nine of the young participants exhibited a LH surge, while 
a similar surge occurred in only one of the eight peri-menopausal women.  
Therefore, it appears that the peri-menopausal HPG axis may have changes that 
involve more than sub-normal ovarian function.   
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 Isolating age-related changes in hypothalamic response from ovarian 
aging is difficult; however, a number of studies have been conducted using the 
rodent model.  These studies have examined the response of the HPG axis at 
various stages in the life cycle of the female as well as the functional changes of 
the hypothalamus and pituitary gland with aging.  Wise and colleagues (Wise, 
1991) have reported decreased amplitude and frequency in LH secretion in older 
rats and a decline in the number of activated GnRH neurons, despite normal 
cycles (Lloyd et al., 1994; Scarbrough and Wise, 1990).  These papers by Wise 
and colleagues and many other papers point to alterations in the systems that 
modulate GnRH as key elements of the reproductive decline.  Overall, these 
studies indicate that hypothalamic response decreases, potentially in tandem 
with declining ovarian function (Micevych et al., 2003; Mills et al., 2002; Wise, 
1991). 
 
MODELS OF OVARIAN AGING AND MENOPAUSE 
Finding appropriate animal models for studying menopause is a debated 
subject with many aspects.  The clinical definition of menopause is the cessation 
of spontaneous menstrual cycling for at least one year.  Primates are unique in 
the animal kingdom with regard to the extensive menstrual sloughing of the 
endometrial lining.  Thus, in the strictest sense of the word, menopause research 
is only possible in animals that experience menses.  Human and even nonhuman 
primate research can be prohibitive due to cost, complex variables in lifestyle, 
history, and time required to study aging systems. Therefore, there is a great 
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need for alternative models of menopause.  The ideal menopause model would 
have similarity to endocrine and neuroendocrine aspects to human ovarian 
biology.  Additionally, if possible, the model should have reproductive traits which 
can be manipulated in the laboratory, i.e. transgene or natural mutations resulting 
in accelerated or delayed example of ovarian aging.  Therefore, it is important to 
be able to compare normal aging to accelerated and/or delayed models as a way 
of elucidating the process as well as the underlying mechanisms contributing to 
the process of aging.  This section will present some of the current research on 
models that have been developed and are being used to study menopause and 
ovarian aging (Table 1.2).  
 
Rodent Models 
Rodent Ovarian Biology.  Most rats will become reproductively mature at 
approximately 5 weeks of age.  At reproductive maturity, they have an estrous 
cycle that lasts 4-5 days regardless of seasonal changes (vom Saal et al., 1994).  
Both rats and mice will begin to exhibit periods of persistent estrous, which is 
associated with elevated, constant levels of estradiol, low levels of progesterone, 
and a lack of LH surges and ovulations (vom Saal et al., 1994).  The tonic levels 
of estradiol lead to stimulation and cornification of the vaginal epithelium, 
resulting in a state of persistent vaginal cornification.  Laboratory mouse and rat 
strains differ with regard to age of ovarian decline both within and between 
species and may occur from 6 to 18 months of age, depending on strain (Felicio 
et al., 1984).  Ultimately, mice and rats will enter a final stage characterized by 
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low plasma estradiol and progesterone levels, as well as little to no remaining 
developing ovarian follicles (Lu et al., 1979).          
 The use of rodent models in ovarian aging research is manifold.  They are 
relatively short-lived and the availability of homogenous laboratory strains permit 
controlled research experiments.  As such, ovarian function in rodents is well 
characterized.  Furthermore, genetic manipulation of specific genes has made it 
possible to study aspects of ovarian decline in transgenic models as well. 
 
Bax-/- Mouse.  Delayed ovarian aging has been documented in a knock-
out mouse model: the Bax-/- mouse.  The exact mechanism by which ovarian 
reserve depletion occurs is unknown, although, atresia and apoptosis are 
certainly involved.  Bax is a member of the Bcl-2 family of proteins which are 
considered to be pivotal in the regulation of cell death pathways (Kim, 2005).  
The Bcl-2 family members are generally classified as either pro-apoptotic, such 
as Bax, Bid and Bad; or anti-apoptotic, such as Bcl-2 and Bcl-XL (Kim, 2005).  
These proteins are believed to exert their apoptotic effects via hetero- and homo-
dimerization (Liu et al., 1996; Sedlak et al., 1995; Yang et al., 1995) and the 
ability to form membrane channels, thereby influencing ion or protein transport 
(Garcia-Saez et al., 2005; Tilly et al., 1995).            
Bax has been localized in both granulosa cells and oocytes (Jurisicova et 
al., 1998; Kugu et al., 1998; Perez et al., 1999).  Upon gross examinations, 20-22 
months aged Bax-deficient female mice exhibited uterine hypertrophy as 
compared to their aged matched controls (Hoyer et al., 2001).  Morphological 
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analyses revealed the presence of multiple follicles at varying stages of 
development, including large antral follicles with visible oocytes.  No indication of 
ovulation (presence of corpora lutea) was noted; however retrieval of oocytes 
following a superovulation protocol indicated that a mixture of normal, mature 
and abnormal oocytes were present in these animals.  As expected the aged 
matched control ovaries chiefly consisted of stromal tissue, lacking evidence of 
follicles or oocytes.   
Investigators performed morphometric analyses to determine if the 
sustained follicle endowment observed in Bax-deficient female mice was 
attributable to a greater initial ovarian follicle reserve (Hoyer et al., 2001).  
Neonatal wild-type and Bax-/- mice were found to have similar numbers of non-
atretic primordial and primary follicles.  Shortly after puberty, however, Bax-/- mice 
exhibited three times the ovarian reserve of their wild type counterparts.  The 
authors hypothesized that the Bax deficiency may have granted some protection 
to the granulosa cells and oocytes against apoptosis.  This model provides a 
unique perspective by delaying, if not eliminating ovarian senescence in the 
mouse.  Bax levels have been shown to be elevated with the initiation of cell 
death in the human ovary (Jurisicova et al., 1998).  Thus, the Bax-deficient 
female mouse model is a useful and intriguing model for studying menopause 
and the decline in the ovarian follicular reserve in women. 
 
 VCD-Treated Rodent.  Rodents treated with 4-Vinylcyclohexene diepoxide 
(VCD) have been shown to exhibit accelerated ovarian failure.  VCD is an 
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industrial chemical that is produced during the production and manufacture of 
insecticides, plasticizers, antioxidants, flame retardants and rubber tires (Doerr et 
al., 1995).  It is being studied with regard to its ovotoxic effects and risk factor for 
premature menopause in women; however it also provides an interesting model 
for accelerated ovarian aging (Doerr et al., 1995; Springer et al., 1996). VCD will 
selectively destroy primordial and primary follicles when administered repeatedly 
to mice and rats (Doerr et al., 1995; Springer et al., 1996).  The exact 
mechanisms by which the ovotoxicant VCD acts to initiate atresia are still largely 
unknown; however, it is believed to act by accelerating the natural processes of 
atresia (Borman et al., 1999; Hu et al., 2001).   Induction of premature ovarian 
failure is thus possible via depletion of the pool of primordial follicles.  The 
mechanism of action by which VCD acts is thought to be via pro-apoptotic 
pathways (Mayer et al., 2002).   
After 30 days of treatments (80 mg/kg VCD per day), Fischer-344 rats had 
significantly reduced numbers of preantral follicles (Hooser et al., 1994).  There 
were no apparent ultrastructural difference between groups; however, circulating 
levels of FSH were elevated by 120 days in VCD-treated as compared to vehicle 
animals.  Furthermore, cyclicity was disrupted in VCD-treated rats by 360 days 
(Hooser et al., 1994).  Experiments in mice yielded similar results: VCD-treated 
mice exhibited elevated levels of circulating FSH and reduced  estradiol, at an 
age where control hormone levels were still normal (Mayer et al., 2004).  
Secondly, androgen levels in VCD-treated mice have also been shown to be 
elevated, similar to post-menopausal hyperandrogenic women (Mayer et al., 
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2004).  Combined, these data demonstrate that the accelerated time-frame of 
onset of ovarian senescence in the VCD-treated mouse supports its use as a 
menopause model, particularly of premature menopause.  Moreover, this model 
may provide insight into the apoptosis-regulated pathways that likely lead to 
ovarian depletion and consequently menopause in women, whether normal or 
premature.  
 
Foxo3a-/- Mouse.  The Foxo3a-/- mouse is another model for accelerated 
ovarian aging.  Foxo3a is a member of the mammalian Foxo subfamily of 
forkhead transcription factors, including Foxo1, Foxo4 and Foxo6 (Brenkman and 
Burgering, 2003).  Foxo transcription factors may be considered analogous to the 
DAF-16 transcription factor (and thus part of the DAF-2 pathway) in the 
roundworm (C.elegans; Kenyon et al., 1993).  This is of considerable interest 
given exciting research which has shown that loss-of-function mutations in DAF-2 
extends lifespan in the roundworm (Hosaka et al., 2004; Kenyon, 2001).  The 
role of Foxo genes in mice is currently being explored; however it is clear that the 
individual genes (foxo1, foxo3a and foxo4) are functionally diverse (Burgering 
and Medema, 2003).  In vitro data suggests a role for Foxo genes in cell cycle 
arrest, apoptosis and specific stress responses (Castrillon et al., 2003; Tran et 
al., 2003). 
More specifically, Foxo3a has been found to be an essential regulator and 
suppressor of follicular activation (Castrillon et al., 2003).  Investigators 
(Castrillon et al., 2003) generated a Foxo3a-/- mouse bearing a null mutation in 
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the Foxo3a locus.  These mice appeared outwardly normal up to 48 weeks of 
age, with no differences in body weight, or increases in cancer, or mortality.  With 
regard to reproduction, however, Castrillon et al. reported sterility in these mice 
by 15 weeks of ages, despite normal sexual maturation (based on first litter).  
Histological analyses of ovaries indicated normal ovaries at postnatal day 3 
(PD3), but by PD8, Foxo3a-/- ovaries were consistently enlarged.  These mice 
exhibited early follicular activation, maturation and atresia, consequently resulting 
in early depletion of ovarian reserve.  By 20 weeks, Foxo3a-/- females 
demonstrated classic signs of hypogonadotropic (elevated FSH and LH), 
hypogonadism, typical of premature ovarian failure.  The authors suggest that 
these results indicate a role for Foxo3a specifically in follicular growth, but not 
other aspects of follicular maturation and reproduction.  Thus, these data suggest 
that accelerated follicular initiation may be an underlying cause for premature 
ovarian failure. 
 
 FSH-R +/- Mouse.  As its name implies, follicle-stimulating hormone (FSH) 
is the main hormone responsible for the processes involved in folliculogenesis, 
including follicular growth, and differentiation (Hillier, 2001).  FSH receptors are 
found exclusively on the granulosa cells in the ovary, and the Sertoli cells in the 
testis; therefore all of its actions occur in these tissues (Camp et al., 1991; 
Zeleznik et al., 1974).  FSH is essential for follicular maturation and the synthesis 
of estradiol from the granulosa cells via theca-derived androgen aromatization 
(Hillier, 2001).  In addition, rats treated with FSH (10 µg/injection, twice daily) 
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have showed a decrease in DNA fragmentation and apoptosis in the ovary, 
suggesting a protective effect of the gonadotropin (Billig et al., 1994).  
Furthermore, some investigators have proposed the idea that ovarian follicles in 
aging females may become refractory to gonadotropin stimulation, impairing 
ovarian response and function (Gosden et al., 1983).  These data, along with 
previously cited data reporting the elevated FSH levels coincident with ovarian 
decline, underline the need to elucidate the role of the FSH receptor in age-
related ovarian failure. 
The follitropin receptor knockout (FORKO) mouse was first characterized 
by Dierich and colleagues (Dierich et al., 1998).  Female FORKO (FSH-R-/-) mice 
are infertile and their ovaries are significantly smaller than their wild-type 
littermates due to a lack of large Graafian follicles and absence of corpora lutea 
(Danilovich et al., 2002).  Conversely, FSH-R haplo-insufficient mice did reach 
reproductive maturity, and it occurred earlier than in their wild-type counterparts.  
Litter sizes in the FSH-R+/- mice were also lower at all observed ages (3, 7 and 
12 months).  Gross examination of ovarian histology in 3-month old mice showed 
little differences between wild-type and FSH-R+/-; however, closer inspection 
revealed evidence of increased numbers of atretic follicles in the FSH-R+/- 
animals.  By 7 months, there was an increase in the numbers of abnormal 
looking follicles, with irregular-looking or double oocytes.  Additionally, although 
there was no difference in the total number of follicles in 3-month FSH-R+/-  
versus wild types, 7 month FSH-R+/- ovaries had significantly reduced numbers of 
oocytes as compared to their age-matched controls.  The accelerated loss of 
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oocytes may be attributable to increase cell death, as the percentage of atretic 
follicles was much increased in the FSH-R+/- animals, at all ages (Danilovich and 
Sairam, 2002).   
Danilovich et al., (Danilovich et al., 2003) have also reported on the 
endocrine alterations in the FSH-R+/- haplo-insufficient mouse.  Young FSH-R+/- 
mice (3 months) have reduced estradiol, but similar pituitary gonadotropin levels 
to their wild-type counterparts.  By 7 months, however, FSH-R+/- mice exhibit 
elevated gonadotropins and reduced estradiol levels (coincident with reduced 
numbers of ovarian follicles).  These data indicate that the FSH-R +/- mouse 
experiences accelerated ovarian aging and may be a useful model for studying 
menopause (Danilovich et al., 2003).  Furthermore, the authors suggest that 
these studies support the hypothesis that declining FSH-R and increasing FSH 
levels in aging females is a result of increased ovarian resistance to follicular 
development (Danilovich et al., 2003).   
 
Primate Models 
Human Ovarian Biology 
In the U.S. menarche occurs in young women at an average age of 12.5 
years (Abma et al., 1997).  Menstruation is unique to primates and occurs as a 
result of sloughing of the endometrial lining.  The menstrual cycle consists of the 
follicular phase and the luteal phase, divided by ovulation.  Each phase lasts 
approximately 14 days, resulting in an median menstrual cycle length of 28 days 
(Vollman, 1977).  Clinical menopause is defined as the period of a woman’s life 
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one year after the cessation of menstrual cycles occurring at a median age of 51 
years (Treloar, 1981).  The events leading to the climacteric begin years earlier 
and are termed the peri-menopausal transition.  Data collected by the Center for 
Disease Control (CDC) have shown that there is a significant age-related 
decrease in the incidence of pregnancy and age-related increases in 
spontaneous miscarriage, ectopic pregnancies and chromosomal abnormalities 
in young women (<30 years; (Ventura et al., 2004).   
The monotropic rise in follicle-stimulating hormone (FSH) is the hallmark 
event indicating the onset of reproductive decline in women, showing significant 
increases in women prior to menstrual irregularity or other endocrine changes 
(Akande et al., 2004).  Increased levels of FSH are evident throughout the cycle; 
however, the difference is most consistent in the early follicular phase.  Day 2-5 
FSH levels have been shown to correlate well with ovarian reserve and provide a  
commonly used biomarker in clinical practices to evaluate and predict pregnancy 
success via artificial reproductive technologies (Navot et al., 1994).              
Use of human subjects for investigating reproductive senescence permits 
the most direct application of research into practice.  Fortunately, the increased 
demand for human artificial reproductive technology (ART) has supported the 
rapid advancement of research in human reproduction.  Unfortunately, some of 
this demand may be due to the trend in postponement of childbearing and the 
increased incidence of infertility with age (te Velde et al., 1998).  Aging in the 
ovary appears to play a more important role in declining fertility than uterine 
aging (Blurton Jones et al., 2002).  Navot and others (Navot et al., 1994) 
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demonstrated that when age of the oocyte donor was controlled, there were no 
significant differences in the delivery rate between young and old recipients.  
Within older cohorts, however, there may be differential fertility; thus, ovarian age 
is not necessarily dictated by chronological age (Bukman and Heineman, 2001).  
Furthermore, ovarian age may be determined by ovarian reserve, and this is 
dependent on the pool of remaining follicles as well as the quality of the oocytes. 
DNA microarray analayses of luteinizing granulosa cells by Chin et al. 
(Chin et al., 2002) demonstrated differences in gene expression between women 
with normal or decreased ovarian reserve.  Diminished ovarian reserve was 
determined based on day 3 FSH and peak serum E2 levels and number of 
oocytes retrieved following an ovarian stimulation protocol.  The authors admit 
the difficulty in interpreting these data, given small sample sizes, differential 
responses within groups, and inconsistent gonadotropin stimulation of subjects.  
It is still of great interest, however, to note that there were changes in a few 
specific genes.  Although inconclusive, these data provide a basis for identifying 
specific gene targets that vary within the ovary during aging that will be useful for 
future research on ovarian aging and menopause in women. 
 
Rhesus Monkey Ovarian Biology       
Since the early 1900’s, the rhesus monkey (Macaca mulatta) has been 
considered a useful model for reproductive studies in women (Heape, 1900).  
Female rhesus monkeys are pubertal by 2.5 to 3.5 years of age and exhibit 
menstrual cycles approximately 28 days in length, similar to women.  Hormonal 
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and menstrual similarities to women have made the rhesus monkey a favored 
model in which to research ovarian function.  Furthermore, rhesus monkeys 
experience a reproductive decline much like that of human menopause at 
approximately 24 years (Gilardi et al., 1997).  One major difference in the 
menstrual cycle of humans versus rhesus monkeys however, is the existence of 
a breeding season in the latter.  Both indoor- and outdoor-housed rhesus 
monkeys experience a breeding season that varies between primate facilities, 
but generally runs from September through May.  Thus, further characterization 
of the onset of ovarian decline in rhesus monkeys was necessary to validate it 
utility as a model for human menopause. 
The first report of a longitudinal assessment of menstrual patterns in aging 
rhesus monkeys was performed by Gilardi, et al. (Gilardi et al., 1997).  Gilardi, et 
al. (Gilardi et al., 1997) reported urinary hormone profiles for 26 peri-menopausal 
rhesus monkeys.  Menstrual records were documented for 12 months prior to the 
urine collection period.  Subsequently, daily urinary estrone conjugate (E1C) and 
pregnanediol-3-glucuronide (PdG) were analyzed for 12 weeks in female rhesus 
monkeys aged 20.5 to 29.5 years (average 23.5).  As expected, the younger 
monkeys (less than 25 years) menstruated regularly, while the older monkeys 
demonstrated an increasing menstrual irregularity.  Similar to women who 
experience low estradiol and irregular progesterone profiles with the onset 
menopause, menopausal rhesus monkeys had low E1C levels as well as irregular 
patterns of PdG.  These data initially suggested parallel events in rhesus 
monkeys and women with regard to menopausal onset. 
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Further research by this group analyzed urinary FSHβ as well as 
circulating inhibin B (INHB) in rhesus monkeys (Shideler et al., 2001).  As 
discussed earlier, elevated circulating FSH is the hallmark event associated with 
the onset of ovarian decline in women.  Twenty female rhesus monkeys between 
18-26 years were analyzed for menstrual cycling, circulating INHB (2 samples 
collected between menstrual cycle day 3-5 and day 10-12), as well as daily 
urinary E1C, PdG and FSHβ for one year.  In agreement with the previous study, 
irregular menstrual cycling was associated with reduced urinary E1C levels.  
Additionally, Shideler, et al. (Shideler et al., 2001) showed that urinary FSH 
levels were elevated in aged females.  Unlike women, however, this elevation 
was only detectable after age-related menstrual irregularities were observed.  
Furthermore, decreases in circulating INHB levels were only detectable in 
ovariectomized monkeys as compared to normally cycling females.  Therefore, 
the researchers acknowledge some key differences between the onset of 
menopause in rhesus monkeys and women.     
 
Other Nonhuman Primates 
Very little data exist characterizing menopause in other nonhuman primate 
species (Bellino and Wise, 2003).  Menopause is simply the cessation of 
menstrual cycling; thus, by definition this is a state that may be achieved by any 
animal that experiences periodic endometrial sloughing and vaginal bleeding, 
including baboons, chimpanzees, gorillas and orangutans (Collins et al., 1975; 
Dahl et al., 1987; Gould et al., 1981).  The baboon has been considered a useful 
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model for various reproductive studies, due to their similarities in menstrual cycle 
characteristics (Kraemer et al., 1977).  Furthermore, the swelling of the perineal 
sex skin permits the noninvasive detection of the follicular phase and 
approximate time of ovulation (Domb and Pagel, 2001; Kraemer et al., 1977).  
Despite the use of the baboon in pregnancy and endometriosis research, 
however, very little had been reported on baboon menopause and the onset of 
reproductive decline.  Menopause research in the great apes has been even less 
prevalent in the literature.  
 
EVALUATING MENOPAUSE: OVARIAN RESERVE TESTS 
 Considering the high price of assisted reproduction, it is often considered 
prudent to estimate the probability of success prior to costly hyperstimulation and 
in vitro fertilization (IVF) regimes.  Age of menopause in women may be highly 
variable, ranging for 10-15 years.  Common to all pre- and peri-menopausal 
patients, however, is the monotropic rise in FSH, which may be attributed to 
changes occurring within hypothalamus and/or reduced feedback from the ovary 
itself.  Evidence for hypothalamic changes with age have been suggested using 
artificially reduced follicle numbers via unilateral ovariectomy in rats (Anzalone et 
al., 2001).  Conversely, comparisons between young and peri-menopausal 
women have showed reduced levels of inhibin B (INHB), elevated activin with no 
change in follistatin, giving support to an ovarian role in the rising levels of FSH in 
menopausal patients (Reame et al., 1998).  Of note is the fact that many of these 
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hormonal changes occur prior to any measurable change in estradiol, 
progesterone or luteinizing hormone (Klein et al., 1996a). 
 d3 FSH.  Ovarian reserve may be assessed clinically, by early follicular 
phase FSH level.  Serum FSH concentration is commonly used as a predictor of 
fertility and likelihood of pregnancy.  Early follicular phase FSH (day 2-5) has 
been shown to correlate well with ovarian reserve.  Measurement of basal FSH 
alone, while extremely useful, can be somewhat variable.  Thus, a number of 
tests have been developed that when used in conjunction with basal FSH levels, 
have been successful in predicting ovarian response.  In general, most of these 
tests rely on assessing hormonal response to ovarian stimulation, whether at the 
level of the hypothalamus, pituitary or direct action on the ovary.   
 EFORT.  Fanchin and colleagues (Fanchin et al., 1994) recently 
developed a supplemental protocol to the standard FSH measurements to 
assess ovarian reserve.  The exogenous follicle stimulating hormone ovarian 
reserve test (EFORT) significantly improved the predictive value of basal FSH 
alone for IVF response.  Subjects were injected with purified FSH on cycle day 3; 
blood was drawn prior to and 24 hours after FSH administration.  Concomitant 
analysis of basal FSH and change in E2 following treatment was found to be 
effective in differentiating between good and poor responders to IVF.  Change in 
INHB following EFORT, has also been shown to correlate well with response to 
IVF (Dzik et al., 2000).   Women with both low baseline INHB levels as well as 
reduced INHB response to EFORT were less responsive to IVF treatment.   
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 CCCT.  The clomiphene citrate challenge test (CCCT) is a similar and also 
highly effective test of ovarian reserve.  CCCT has been proven to be 93% 
effective in predicting infertility and was more successful in identifying low 
ovarian reserve patients than basal FSH alone (Kahraman et al., 1997).  In 
young, healthy ovaries, ovarian reserve may be associated with an ample 
number of developing follicles.  Administration of clomiphene citrate (CC), a 
hypothalamic estradiol receptor blocker, results in upregulation of FSH and LH 
from the pituitary.   
Clomiphene citrate is an orally active non-steroidal chemical that is a 
mixture of two isomers: zuclomiphene and euclomphene; zuclomiphene being 
more active of the two (Speroff et al., 1999).  Clomiphene itself, is weakly 
estrogenic, however due to its ability to bind receptor for long periods of time, it 
reduces negative feedback and increased gonadotropins, likely via activation of 
GnRH secretion. This stimulates follicular growth and subsequent production of 
inhibin and estradiol (Speroff et al., 1999).  In the case of a peri-menopausal 
ovary, reduced follicle number results in a reduced inhibin response and 
presumably reduced negative feedback at the level of the pituitary and/or 
hypothalamus.   
In human clinical trials, the CCCT is commonly used in conjunction with 
day 3 (with onset of mense as day 1 of the menstrual cycle) FSH levels to predict 
relative ovarian reserve.  Patients are hormonally monitored to determine 
cyclicity, using P4 and LH.  Basal FSH and E2 are measured in early follicular 
phase (days 2-5), and 100 mg clomiphene citrate is administered orally once 
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daily in mid follicular phase (days 5-9).  FSH and E2 are measured in late 
follicular phase (days 9-11).  The results of the basal versus clomiphene citrate-
stimulated FSH and E2 may be used to predict relative IVF success.  Cessation 
of CC results in suppression of FSH, likely via endogenous ovarian inhibins.  
INHB may be measured in combination with the CCCT as a direct measure of 
ovarian responsiveness.  It has been shown that women with normal ovarian 
reserve have higher granulosa cell INHB production as compared with women 
with diminished ovarian reserve (Hofmann et al., 1998).  Thus, the results of the 
CCCT are evaluated considering that younger women with a large ovarian 
reserve will respond to CCCT with a dramatic change in estradiol, comparing 
basal to stimulated hormone levels.  Older women with significantly reduced 
ovarian reserve respond to CCCT with little to no change in estradiol, when 
comparing basal to stimulated hormone levels. 
Ovarian Volume.  Ultrasound may also be performed to evaluate ovarian 
activity in response to gonadotropin stimulation.   Decreased ovarian volume may 
be observed earlier than initial rising concentrations of FSH (Syrop et al., 1995).  
Patients with ovaries less than 3 cm3 were associated with a poorer response to 
human menopausal gonadotrophin stimulation than similarly aged patients with 
larger ovaries (Lass et al., 1997).  Lass and Brinsden (Lass and Brinsden, 1999) 
reviewed the utility of ovarian volume in reproductive medicine and cited 
evidence for a correlation between ovarian volume and the number of primordial 
follicles in older women (>35 years).  Additionally, ultrasound may be used to 
assess the number of small, antral follicles that has been shown to correlate 
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negatively with age (Scheffer et al., 1998).  This is a relatively non-invasive and 
inexpensive method by which to evaluate ovarian reserve that may be used with 
other hormonal parameters. 
 
DELAYING MENOPAUSE AND OVARIAN AGING 
Calorie Restriction and General Aging 
 Calorie restriction (CR) is the only non-genetic method of altering longevity 
and other biological processes associated with aging.  To address the relevance 
of this nutritional intervention to human aging, the National Institute on Aging 
began the first study of CR and aging in non-human primates using rhesus 
monkeys to determine its potential application in humans.  These animals were 
gradually restricted until a 30% calorie restricted diet had been reached.  The diet 
was supplemented with additional vitamins and minerals to guard against 
malnutrition (Ingram et al., 1990).  Several endpoints have been investigated in 
studying the long-term effects of CR on aging.  For obvious reasons, the CR 
animals weigh less and have less body fat.  These effects were evident within 3 
years of CR.  CR monkeys have reduced trunk fat and demonstrate reduced 
levels of triglycerides and cholesterol and increased levels of high-density 
lipoproteins (HDLs).  Furthermore, they have reduced fasting glucose and insulin 
levels as compared to controls, suggestive of alterations in glucoregulation.  
These data provided early evidence of the potential benefit of CR for the risk for 
diabetes and cardiovascular disease (Lane et al., 1999). 
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 The Wisconsin Regional Primate Research Center initiated a sister study 
reporting the effects of long-term dietary restriction in male rhesus monkeys and 
later female monkeys.  Gresl and colleagues (Gresl et al., 2001) studied the 
effects of moderate dietary restriction (70% baseline intake) after 8.5 years 
(beginning at 8-14 years of age).  These investigators confirmed earlier reports 
chronic dietary restriction has protective effects against the development of 
insulin resistance as well as improved glucoregulatory parameters in aging 
rhesus monkeys. 
Bone loss with aging is an important health concern and macaques have 
been shown to be an appropriate model in which to study skeletal effects of 
aging with regard to menopause (Black et al., 2001; Colman et al., 1999).  Body 
weight and lean mass are related to bone mineral density and bone mineral 
content in multiple sites.  Consequently, CR monkeys display reduced bone 
mass in specific sites; however, calcium homeostasis and bone turnover are not 
different from control animals.  Therefore, although CR does not appear to retard 
or reverse age-associated bone, neither does it have negative effects on the 
system (Lane et al., 2001).   
 
Calorie Restriction and Ovarian Aging 
 Extension of ovarian lifespan has been well characterized in the rodent, 
using CR protocols.  Although the exact mechanisms of action explaining how 
this occurs is still largely unknown, it is believed to act by altering and/or 
improving the function of a variety of physiological systems.  Reproductive 
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studies in CR rodents have also been performed.  Rats maintained at 50% body 
weight (as compared to control littermates) still achieved sexual maturation, 
albeit delayed (Merry and Holehan, 1979).  Onset of puberty in CR rats was 
observed once animals reached body weights similar to pubertal controls 
(Holehan and Merry, 1985c).  The onset of reproductive decline, however, was 
significantly delayed as well (Holehan and Merry, 1985c; Merry and Holehan, 
1979).    Nelson et al. (Nelson et al., 1985) evaluated ovarian reserve in CR 
(alternate day fasting) mice.  The investigators found that in mice, CR 
suppressed estrous cyclicity, and a return to ad libitum feeding restored cyclicity.  
Histological data demonstrated that CR rats had twice the number of primordial 
follicles as their age-matched controls.  Furthermore, CR mice maintained 
cyclicity at an age when their age-matched controls were 80% acyclic.  
Therefore, calorie restriction may delay reproductive senescence either by 
delaying puberty or initiating a period of ovarian “rest.”   
More recent data suggest that caloric restriction affects reproductive 
longevity at the level of the hypothalamus and/or pituitary (McShane and Wise, 
1996).  Investigators have found that female rats restricted to 60% of ad libitum 
feeding after the onset of puberty did not experience any interruption of normal 
cycling, but delayed cessation of estrous cycles was still observed.  Therefore, 
they concluded that caloric restriction affected the reproductive system in rats by 
a mechanism other than simply delaying puberty or disrupting normal cycling.  
McShane and Wise (McShane and Wise, 1996) hypothesize that caloric 
restriction may actually preserve the reproductive neuroendocrine axis, allowing 
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for prolonged reproductive ability in these animals.  In control animals, LH 
concentration and pulse amplitude decline with age; however, CR animals 
demonstrated enhanced LH secretion and this may be attributable to some 
enhanced pituitary or hypothalamic factor(s).  It was suggested that neuropeptide 
Y could be involved in such effects, since it has been shown to increase during 
periods of food restriction. 
 Due to the apparent success in delaying senescence in rodents, work is 
currently being undertaken to study the effects of caloric restriction in the non-
human primate.  Experiments have been conducted to assess the issue of bone 
loss with respect to energy restriction.  Rhesus monkeys experience menopause 
similar to humans and as such are a good model for assessing age-related bone 
loss (Colman et al., 1999).  Data showed that moderate (30%) long-term energy 
restriction does not affect bone mineral density, bone mineral content, 
osteocalcin, 25-hydroxyvitamin D or parathyroid hormone concentrations (Lane 
et al., 2001).  Therefore, the impact for use of caloric restriction without 
consequence to bone mass may be seriously considered.  Investigators also 
assessed reproductive health in these monkeys and documented no interruption 
of regular cyclicity.  Results suggest that energy restriction did not negatively 
affect the monkeys; however, they did not appear to exhibit any retardation of 
age-related changes either.  Recent evidence in young, short-term (three 
months) CR rhesus monkeys also showed evidence of continued cycling; 
however, data on older monkeys have yet to be determined.  Thus far, the data 
suggest that energy restriction is not overly traumatic to the reproductive system; 
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however, effects of CR on normal reproductive parameters are still not well 
studied.  Lane et al. (Lane et al., 2001) did not detect any CR-related differences 
in the reproductive cycling of young and menopausal animals; however, there 
was little information regarding the peri-menopausal period, which is a critical 
transition period.  Therefore, more studies need to be completed to fully 
understand the potential impact of CR on female reproduction. 
 
SUMMARY  
 Clinical menopause is defined as the period of a woman’s life one year 
after the cessation of menstrual cycles, however, the events leading to the 
climacteric begin years earlier and are termed the peri-menopausal transition.  
Data collected by the Center for Disease Control (CDC) have shown that there is 
a significant age-related decrease in the incidence of pregnancy and age-related 
increases in spontaneous miscarriage, ectopic pregnancies and chromosomal 
abnormalities in young women (<30 years;(Ventura et al., 2004).  This is a 
forbidding reality, especially with an increasing number of women choosing to 
start their careers before starting families (te Velde et al., 1998).  The obvious 
impact of potential infertility in young women notwithstanding, the long-term 
consequences of menopause cannot be dismissed.  The average age of 
menopause in women is approximately 51 years, resulting in a post-reproductive 
period that extends for nearly 1/3 of a woman’s life (Treloar, 1981).  Multiple non-
reproductive systems are affected by the sudden withdrawal of hormonal support 
that is associated with menopause, including bone and cardiovascular health 
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(Gosden, 1985; Prior, 1998).  Menopause is a biological inevitability for all 
women, yet little is known about its progression.  There is a great need to 
develop useful models and indices to mark the progression of the peri-
menopause.  Furthermore, research into methods by which menopause may be 
delayed, such as calorie restriction (or CR mimetics) would be extremely 
beneficial and timely. 
The collaborative effort between the National Institute on Aging, the 
Oregon Health and Sciences University (OHSU) and the University of Maryland 
has made possible a comprehensive analysis of the effects of moderate CR in 
both short- and long-term regimens, on reproductive function in young and peri-
menopausal rhesus monkeys.  Therefore, the objectives of this project were to: 
1) analyze general hormonal changes that occur with aging and menopause and 
2) evaluate the effects (whether beneficial or detrimental) of moderate (30%) CR 































Figure 1.1 Hypothalamic Pituitary Gonadal Axis.  Schematic representation 
of the hypothalamic pituitary gonadal axis and the major hormones involved.  
Hypothalamic production of gonadotropin releasing hormone (GnRH) stimulates 
pituitary production of gonadotropins follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH).  Ovarian response to gonadotropins stimulated the 






Table 1.1 Summary of evolutionary hypotheses and theories of menopause. 
Evolutionary  
Hypothesis or Theory Description 
Good Mother Hypothesis Risk of pregnancy resulting in a trade-off between an increased 
number of children and ability to successfully raise them 
(Alexander, 1974; Nesse and Williams, 1996; Sherman, 1998) 
  
Grandmother Hypothesis Re-allocation of reproductive effort from production of own offspring 
to caring for offspring already born and/or children's offspring 
(Gibbons, 1997; Hawkes et al., 1998; Williams, 1957) 
  
Disposable Soma Theory Favoring of reproductive systems over maintenance and repair 




Table 1.2 Summary of Research Models of Ovarian Aging and Menopause 
Animal Model Phenotype 
Rodent Mouse / Rat Normal ovarian senescence: ~6-18 months  
(Felicio et al., 1984; Johnson, 2000b; Lu et al., 1979; vom 
Saal et al., 1994) 
 Calorie Restricted Rat Delayed ovarian senescence  
(Holehan and Merry, 1985b; Merry and Holehan, 1979; 
Nelson et al., 1985) 
 Bax -/- Mouse Delayed ovarian senescence  
(Hsu et al., 1997; Kim, 2005; Kugu et al., 1998; Liu et al., 
1996; Oltvai et al., 1993; Sedlak et al., 1995; Tilly et al., 
1995; Yang et al., 1995) 
 VCD-Treated 
Mouse/Rat 
Accelerated ovarian senescence  
(Borman et al., 1999; Doerr et al., 1995; Hooser et al., 
1994; Hoyer et al., 2001; Hu et al., 2001; Mayer et al., 
2002; Springer et al., 1996) 
 Foxo3a-/- Mouse Accelerated ovarian senescence  
(Brenkman and Burgering, 2003; Burgering and Medema, 
2003; Castrillon et al., 2003; Hosaka et al., 2004; Kenyon, 
2001; Kenyon et al., 1993; Tran et al., 2003) 
 FSH-R+/- Mouse Accelerated ovarian senescence  
(Billig et al., 1994; Camp et al., 1991; Danilovich et al., 
2002; Danilovich and Sairam, 2002; Dierich et al., 1998; 
Gosden et al., 1983; Hillier, 2001; Zeleznik et al., 1974) 
   
Primate Human Normal ovarian senescence: ~50 years  
(Abma et al., 1997; Akande et al., 2004; Bukman and 
Heineman, 2001; Chin et al., 2002; Navot et al., 1994; 
Treloar, 1981; Ventura et al., 2004; Vollman, 1977)   
 Rhesus Monkey Normal ovarian senescence: ~24 years  




MENSTRUAL CYCLING WITH PERI-MENOPAUSE IN RHESUS MONKEYS 
AND THE EFFECTS OF CALORIE RESTRICTION 
 
INTRODUCTION 
Calorie restriction (CR) is a paradigm of life extension that was first 
reported in the mid 1930’s (McCay et al., 1935).  It remains the only proven non-
genetic and nutritional experimental paradigm for life extension, retarding aging 
processes in many species, including rats, mice, fish, hamsters, fruit flies and 
nematodes (Roth et al., 1999; Sinclair, 2005; Smith et al., 2004). Its long history 
notwithstanding, very little is known with regard to the mechanism of action of 
CR.  Its effects on age-related illnesses are currently being investigated.  
Furthermore, moderate CR in rats has been shown to delay the onset of ovarian 
decline (Holehan and Merry, 1985b; Merry and Holehan, 1979).   
The median age of menopause in women is 51 years (Treloar, 1981).  The 
associated health risks that accompany the climacteric are well known, including 
cardiovascular, cognitive and skeletal diseases (Johnson et al., 2004; Nappi et 
al., 1999; Prior, 1998; Sherwin, 2003).  Despite this, there remains only a modest 
understanding of how and why menopause occurs.  Use of potentially 
inappropriate animal models (species that do not have a “true” menopause) may 
also confuse the science behind the precipitous decline reproductive function in 
women (Wu et al., 2005). 
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The rhesus monkey is an ideal animal model in which to study ovarian 
function and decline in women.  Rhesus monkeys exhibit menstrual cycles 
comparable to women, both hormonally and with regard to the endometrial 
sloughing of the uterine lining (Heape, 1900).  Limited data have demonstrated 
that rhesus monkeys undergo menopause similar to women at approximately 25 
years (Gilardi et al., 1997).  Morphometric follicular counting techniques have 
also been used to characterize changes in ovarian reserve (follicular number) in 
both pigtail and rhesus macaques (Miller et al., 1999; Nichols et al., 2005).  
Unlike other laboratory animal models, such as the rat and mouse, rhesus 
monkeys may be monitored for cessation of menstruation (true menopause) as is 
practiced in human clinics. 
In rats, moderate CR delays the onset of ovarian decline, typical in aging 
females (Holehan and Merry, 1985b; Merry and Holehan, 1979). The effects of 
CR in primates are largely unknown (Mattison et al., 2003); however, we 
previously reported that CR did not appear to negatively impact menstrual cycles 
or hormone profiles in our rhesus monkeys (Wu et al., 2004).  The effects of CR 
on delaying menopause, however, have yet to be determined.  A controlled delay 
of menopause could beneficially impact multiple systems beyond reproduction, 
including a reduction in the incidence of cardiovascular disease, bone fragility, 
cognitive deficits and certain cancers.   Therefore the objective of this experiment 
was two-fold: 1) to evaluate hormone changes that occur with normative aging 
and onset of peri-menopause; and 2) to determine what effects (either beneficial 
or detrimental) CR has on menstrual cycling in rhesus monkeys. 
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MATERIALS AND METHODS 
Animals and Diet 
Adult female rhesus monkeys (Macaca mulatta), exhibiting normal body 
weights (4.5-7.0 kg) and regular menstrual cycles of about 28 days were housed 
under controlled conditions of temperature (22°C) and a standard daily light-dark 
cycle (12 h light: 12 h dark).  The veterinary staff provided animal care and 
housing.  Additionally, all procedures were approved by the Institutional Animal 
Care & Use Committee (IACUC) at the Oregon National Primate Research 
Center and the Animal Care and Use Committee (ACUC) of the NIA, in 
accordance with the NIH Guide for the Care and Use of Laboratory Animals.  
Body weights of each animal were assessed monthly.  Two colonies of monkeys 
were used in this study: 1) National Institute on Aging (NIA; Poolesville, MD), 2) 
Oregon National Primate Research Center (ONPRC), Oregon Health and 
Sciences University (OHSU; Beaverton, OR). 
Prior to implementation of the CR feeding regimen, monkeys were 
monitored to determine daily food intake based on ad libitum feed availability.  
The average daily value was then divided into two meals.  Feed allotment was 
adjusted for young, growing monkeys maintained in the long-term study.  CR 
monkey diet was reduced by 10% per month until a 30% CR was achieved. 
 
Short-Term (ONPRC) Colony: Monkeys housed at the ONPRC colony were 
maintained on the CR diet for 1-2 years.  Breakdown of animal groups are as 
follows in Table 2.1. 
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Table 2.1  Short-term (ONPRC) Animal Distribution. Animal ages and 
numbers for the colony housed at the Oregon National Primate Research Center 
(ONPRC).  The calorie restriction (CR) protocol was maintained for 1-2 years. 
ONPRC Age* N 
YCON 10 ± 0 4 
YCR 10 ± 0 5 
OCON 23 ± 0.9 8 
OCR 22 ± 0.8 7 
*Age in years at time of sampling 
Long-Term (NIA) Colony: Monkeys housed at the NIA colony have been 
maintained on the CR diet for 11-12 years.  Breakdown of animal groups are as 
follows in Table 2.2. 
Table 2.2  Long-term (NIA) Animal Distribution. Animal ages and numbers for 
the colony housed at the National Institute on Aging (NIA).  The calorie restriction 
(CR) protocol was maintained for 11-12 years. 
NIA Age* N 
YCON 14 ± 0.3 6 
YCR 14 ± 0.2 7 
OCON 20 ± 1.1 6 
OCR 20 ± 1.5 5 
*Age in years at time of sampling  
Blood Collection and Hormone Analyses: 
Monkeys were monitored for onset of menses (designated Menses d1).  
Serum was collected from un-anesthetized monkeys from the saphenous vein for 
3 cycles (or approximately 90 days) following a spontaneous menses: daily 
during the follicular phase and every third day during the luteal phase.  
Circulating hormones were assayed for estradiol (E2) and progesterone (P4) by 
specific electrochemoluminescent assay using a Roche Elecsys 2010 assay 
instrument at the Endocrine Services Laboratory Core, ONPRC (Beaverton, OR).  
Luteinizing hormone (LH) was determined using a Leydig cell bioassay and 
follicle-stimulating hormone (FSH) was determined using an in-house 
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radioimmunoassay (RIA).  Hormone concentrations were validated against 
previous RIAs in this laboratory (Hess et al., 1981; Zelinski-Wooten et al., 1995). 
Inhibin B was determined using the commercially available Active Inhibin 
B kit (Diagnostic Systems Laboratory; Webster, TX).  This ELISA was validated 
for use with rhesus monkey serum in our laboratory.  Parallel displacement 
curves were obtained by comparing serially diluted (1:1 to 1:16) pooled rhesus 
monkey serum against known INHB concentrations.  Recovery of known 
concentrations of unlabeled INHB added to pooled rhesus monkey serum was 
100% with a coefficient of variation of 10%.  Inter-assay coefficients of variation 
for two internal controls were 15% and 9%.  The intra-assay coefficient of 
variation was always less than 10%.   
 
Hormone Profiles Relative to Mid-Cycle LH peak 
All hormones (LH, FSH, E2, P4 and INHB) were retrospectively 
synchronized relative to the estimated mid-cycle LH peak (designated LH d0).  
This separates the follicular and luteal phases to permit analyses between 
comparable physiological states.  Monkeys were assigned to one of two groups: 
regular cyclers (≥2 cycles demonstrating a mid-cycle E2 peak followed by luteal 
phase levels of P4) and irregular cyclers).  Hormone levels were averaged for 
each female exhibiting regular cycles across the three consecutive cycles and 
subsequently averaged within age and diet groups (YCON, YCR, OCON, OCR).  
Irregular cyclers could not be included in these analyses due to lack of 
information (i.e. LH peak).   
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Hormone Profiles Relative to the Onset of Menses 
A second analysis was performed using early follicular phase hormones 
following onset of menses (designated Menses d1).  E2, FSH and INHB were 
aligned by Menses d1.  Based on the classification of regular and irregular 
cyclers, defined above, monkeys were divided into 6 groups: YCON, YCR, 
OCON Regular Cyclers (OR-CON), OCR Regular Cyclers (OR-CR), OCON 
Irregular Cyclers (OI-CON) and OCR Irregular Cyclers (OI-CR).  In specific cases 
where menses did not occur, nadirs (< 50 pg/mL) in E2 patterns were used and 
assigned as d1.   
 
Short-Term (ONPRC): Menses Records in the Third Year 
 These data were collected as part of a larger experiment which continued 
into a third year on CR.  Subsequent to our 90-day sampling period (performed 
after 1-2 years on CR), record-keeping on menses events persisted until the 
completion of the experiment at three years.  Using Gilardi and colleagues’ 
(Gilardi et al., 1997) definition, we classified a monkey as an irregular cycler if it 
exhibited 6 consecutive months or more of irregular cycles, excluding the non 
breeding season (June through August).   
 
Statistical Analysis  
Data are expressed as mean ± SEM for each parameter measured in 
each group.  Standard descriptive statistics were performed.  Log transformation 
of hormones was necessary and homogeneity of variances and normality of 
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residuals were tested.  Hormones were analyzed by 2-way ANOVA repeated 
measures, followed by Tukey’s for post-hoc comparisons (SAS; Cary, NC) and 
significant differences were established at p < 0.05. 
  
RESULTS 
Short-Term (ONPRC): Individual Hormone Profiles 
 Figures 2.1 depicts representative estradiol (E2) and progesterone (P4) 
graphs for three consecutive menstrual cycles in regular cyclers for YCON (A), 
YCR (B), OCON (C) and OCR (D) monkeys housed for short-term at the ONPRC 
facility.  Regular cyclers included monkeys exhibiting ≥ 2 cycles with a mid-cycle 
E2 peak followed by luteal phase levels of P4.  All of the young monkeys were 
categorized as regular cyclers, while five of eight OCON and five of seven OCR 
were classified as regular cyclers (Table 2.3). 
Table 2.3 Distribution of Regular and Irregular Cyclers in Old Short-Term 
(ONPRC) Group.  Regular cyclers included monkeys exhibiting ≥ 2 cycles with a 
mid-cycle E2 peak followed by luteal phase levels (> 1 ng/mL) of P4.  All young 
monkeys cycled regularly. 
ONPRC Regular Cyclers Irregular Cyclers Total 
OCON 5 3 8 
OCR 5 2 7 
 
 Figure 2.2 depicts individual E2 and P4 graphs for approximately 90 days 
in OCON Irregular Cyclers housed short-term at the ONPRC facility.  Three of 
eight OCON exhibited irregular cycles.  In figure 2.2A, no menses data were 
collected over the course of the 90-day observation period.  A single mid-cycle 
E2 peak occurred, followed by normal luteal phase levels of P4.  In Figure 2.2B, 
two menses incidences were recorded, although the first incident may not be 
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considered a “true” menses due to the lack luteal phase levels of P4 preceding 
the event.  This is an example of break through bleeding (BTB) which occurs 
following an extended period of E2-induced endometrial proliferation.  In Figure 
2.2C, the monkey displayed very low levels of E2 and P4, comparable to 
expected hormone profiles from an ovariectomized animal, with no recorded 
menses activity and little to no change in both E2 and P4. 
 Figure 2.3 depicts individual E2 and P4 graphs for approximately 90 days 
in OCR Irregular Cyclers maintained on short-term CR (1-2 years) at the ONPRC 
facility.  Two of seven OCR exhibited irregular cycles.  Figure 2.3A presents 
another example of very low hormone activity, with no recorded menses noted 
and little to no change in both E2 and P4.  Hormone levels in Figure 2.3B 
indicate that the monkey was mid-luteal when blood sampling was initiated.  
Three menses events were recorded and a single normal cycle occurred (with a 
mid-cycle E2 peak and luteal phase levels of P4).  The third menses event may 
not be considered a “true” menses due to the lack of luteal phase levels of P4 
preceding the menses and is likely due to BTB. 
 
Short-Term (ONPRC): Mean Hormone Profiles 
 Figure 2.4 depicts mean hormone levels for each female exhibiting regular 
cycles across three consecutive menstrual cycles and normalized to the 
estimated mid-cycle LH peak (d=0).  As described above, only regular cyclers 
were included in these analyses.  All YCON (n=5) and YCR (n=5) were included 
while 5 of 8 OCON and 5 of 7 OCR were included (Table 2.3).  Due to financial 
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limitations, selected days were chosen for hormone analyses for LH (three days 
before and after the expected LH peak), FSH (follicular phase) and INHB 
(follicular phase).  A summary of the statistical differences is outlined in Table 
2.4. 
Table 2.4 Short-Term (ONPRC) Summary Statistics Relative to LH Peak. 
Summary of statistical analyses for mean hormone profiles normalized relative to 
estimated LH peak (d=0).  Differences (p< 0.05) are indicated in bold.  Individual 
comparisons were not applicable (NA) when overall differences were not 
observed.  “>” or “<” indicates the relative difference between the groups under 
comparison.  
Comparison LH FSH E2 P4 INHB 
Y vs. O < < = = > 
CON vs. CR NA > = = = 
YCON vs. YCR NA = NA NA NA 
YCON vs. OCON NA < NA NA NA 
YCON vs. OCR NA = NA NA NA 
YCR vs. OCON NA < NA NA NA 
YCR vs. OCR NA = NA NA NA 
OCON vs. OCR NA = NA NA NA 
 
 Figure 2.4A depicts mean LH levels for regularly cycling YCON, YCR, 
OCON and OCR monkeys.  Young monkeys had significantly lower LH levels as 
compared to Old monkeys, however no diet effects were observed.  Figure 2.4B 
depicts mean FSH levels.  Young monkeys had significantly lower FSH levels as 
compared to Old monkeys.  CON monkeys also displayed higher FSH levels 
compared to CR monkeys.  Figure 2.4C-D depicts mean E2 and P4 levels, 
respectively.  Both E2 and P4 levels were similar between ages and diet.  Figure 
2.4E depicts mean INHB levels.  Young monkeys had significantly higher INHB 
levels as compared to Old monkeys, and no diet effects were observed.     
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 Figure 2.5 and Figure 2.6 depict mean hormone levels for each female, 
averaged across three consecutive menstrual cycles or approximately 90 days 
and normalized to the onset of menses or nadirs (<50 pg/mL) in E2 patterns 
(designated Menses d1).  Regular and irregular cyclers were classified as 
defined above.  All Young monkeys cycled regularly; however, Old monkeys 
were divided into either Old, Regular (OR-CON, OR-CR) or Old, Irregular (OI-
CON, OI-CR).  Clinical data in humans demonstrate the early follicular phase to 
be temporally more sensitive in identifying differences between ages.  Therefore, 
we focused on Menses d1-d5.  A summary of the statistical differences is 
outlined in Table 2.5. 
Table 2.5 Short-Term (ONPRC) Summary Statistics Relative to Onset of 
Menses. Summary of statistical analyses for mean hormone profiles with 
comparisons on Menses d1-d5.  Differences (p< 0.05) are indicated in bold.  “>” 
or “<” indicates the relative difference between the groups under comparison.   
Comparison FSH INHB 
Y vs. O < > 
CON vs. CR = = 
Y vs. OR < > 
Y vs. OI = > 
OR vs. OI > > 
 
 Figure 2.5 depicts FSH levels for YCON, YCR, OR-CON, OR-CR, OI-CON 
and OI-CR on menses d1-d5.  Young monkeys had significantly lower FSH levels 
than Old monkeys; however there were no diet effects.  OR monkeys had the 
highest levels of FSH, while FSH in OI and Y monkeys were similar. 
 Figure 2.6 depicts INHB levels for YCON, YCR, OR-CON, OR-CR, OI-
CON and OI-CR on menses d1-d5.  Young monkeys had significantly higher 
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INHB levels than Old monkeys, with no diet effects.  OI monkeys had the lowest 
levels of INHB, with OR monkeys intermediate and Y monkeys highest.  
   
Long-Term (NIA): Individual Hormone Profiles 
Figure 2.7A-D depicts representative estradiol (E2) and progesterone (P4) 
graphs for three consecutive menstrual cycles in regular cyclers for YCON (A), 
YCR (B), OCON (C) and OCR (D) monkeys housed for long-term at the NIA 
facility.  Regular cyclers included monkeys exhibiting ≥ 2 cycles with a mid-cycle 
E2 peak followed by luteal phase levels of P4.  All of the young monkeys were 
categorized as regular cyclers, while three of six OCON and one of five OCR 
were classified as regular cyclers (Table 2.6). 
Table 2.6 Distribution of Regular and Irregular Cyclers in Old Long-Term 
(NIA) Group.  Regular cyclers included monkeys exhibiting ≥ 2 cycles with a 
mid-cycle E2 peak followed by luteal phase levels (> 1 ng/mL) of P4.  All young 
monkeys cycled regularly.   
NIA Regular Cyclers Irregular Cyclers Total 
OCON 3 3 6 
OCR 1 4 5 
 
 Figure 2.8 depicts individual E2 and P4 graphs for approximately 90 days 
in OCON Irregular Cyclers housed for long-term at the NIA facility.  Three of six 
OCON exhibited irregular cycles.  In figure 2.8A, blood collections were started 
just prior to the mid-cycle E2 peak, followed by a normal luteal phase levels of P4 
and subsequent menses.  No further menses data were collected, and E2 was 
normal for basal levels, although no further peaks or luteal phases were 
observed.  Figure 2.8B presents another example of extremely low levels of 
hormones, with an absence of hormone cycling.  Although no E2 peak was 
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detected, low, normal P4 luteal phase levels were observed.  Figure 2.8C shows 
a singe normal cycle with a record of menses followed by a mid-cycle E2 peak 
and luteal phase levels of P4.  This was followed by a period of very low levels of 
hormone activity and no further menses observations.  
 Figure 2.9 depicts individual E2 and P4 graphs for approximately 90 days 
in OCR Irregular Cyclers housed on long-term CR (11-12 years) at the NIA 
facility.  Four of five OCR exhibited irregular cycles.  Figure 2.9A shows three 
recorded menses; however, the second incident is likely break through bleeding 
(BTB), due to the absence of a preceding luteal phase.  E2 appeared to peak 
initially but failed to induce ovulation and luteal production of P4.  This was 
followed by a normal cycle.  Figure 2.9B shows cycling E2 levels with no peaks, 
ovulations or documented menses.  Figure 2.9C also shows cycling E2 levels, 
with no ovulations; however, multiple menses events were recorded.  These are 
likely a product of BTB.  Figure 2.9D shows a mid-cycle E2 peak that was 
followed by very low levels of P4 and subsequent menses.  This was followed by 
cycling levels of E2 and another peak that was followed by very low levels of P4.  
 
Long-Term (NIA): Mean Hormone Profiles 
 Figure 2.10 depicts mean hormone levels for each female exhibiting 
regular cycles, averaged across three consecutive menstrual cycles and 
normalized to the estimated mid-cycle LH peak (d=0).  As described above, only 
regular cyclers were included in these analyses.  All YCON (n=6) and YCR (n=7) 
were included while 3 of 6 OCON and 1 of 5 OCR were included.  Selected days 
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were chosen for hormone analyses for LH (three days before and after the 
expected LH peak), FSH (follicular phase) and INHB (follicular phase).  A 
summary of the statistical differences is outlined in Table 2.7. 
Table 2.7 Long-Term (NIA) Summary Statistics Relative to LH Peak. 
Summary of statistical analyses for mean hormone profiles normalized relative to 
estimated LH peak (d=0).  Individual comparisons were not applicable (NA) when 
overall differences were not observed.  “>” or “<” indicates the relative difference 
between the groups under comparison.  
Comparison LH FSH E2 P4 INHB 
Y vs. O = = = = = 
CON vs. CR = = = = = 
YCON vs. YCR NA NA NA NA NA 
YCON vs. OCON NA NA NA NA NA 
YCON vs. OCR NA NA NA NA NA 
YCR vs. OCON NA NA NA NA NA 
YCR vs. OCR NA NA NA NA NA 
OCON vs. OCR NA NA NA NA NA 
 
 Figures 2.10A-E depict mean LH, FSH, E2, P4 and INHB levels for 
regularly cycling YCON, YCR, OCON and OCR monkeys.  Hormones were 
similar between ages and diets for all hormones. 
 Figure 2.11 and Figure 2.12 depict mean hormone levels for each female, 
averaged across three consecutive menstrual cycles or approximately 90 days 
and normalized to the onset of menses or nadirs (<50 pg/mL) in E2 patterns 
(designated Menses d1).  Regular and irregular cyclers were classified as 
defined above.  All Young monkeys cycled regularly; however, Old monkeys 
were divided into either Old, Regular (OR-CON, OR-CR) or Old, Irregular (OI-
CON, OI-CR) groups. Focusing again on Menses d1-d5, a summary of the 
statistical differences is outlined in Table 2.8. 
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Table 2.8 Long-Term (NIA) Summary Statistics Relative to Onset of Menses. 
Summary of statistical analyses for mean hormone profiles with comparisons on 
Menses d1-d5.  Differences (p< 0.05) are indicated in bold.  “>” or “<” indicates 
the relative difference between the groups under comparison.  
Comparison FSH INHB 
Y vs. O < > 
CON vs. CR = = 
Y vs. OR = = 
Y vs. OI < > 
OR vs. OI < > 
 
 Figure 2.11 depicts FSH levels for YCON, YCR, OR-CON, OR-CR, OI-
CON and OI-CR on menses d1-d5.  Young monkeys had significantly lower FSH 
levels than Old monkeys, however there were no diet effects.  Young and OR 
FSH levels were similar, however, Young monkeys had lower FSH levels as 
compared to OI monkeys.  Additionally, OR monkeys had lower FSH levels than 
OI monkeys. 
 Figure 2.12 depicts INHB levels for YCON, YCR, OR-CON, OR-CR, OI-
CON and OI-CR on menses d1-d5.  Young monkeys had significantly higher 
INHB levels than Old monkeys, with no diet effects.  As with FSH levels, Young 
and OR monkeys had similar INHB levels.  Young monkeys had higher INHB 
levels than OI; OR monkeys had higher INHB levels than OI as well. 
 
Short-Term (ONPRC): Menses Records in the Third Year 
 Short-term (ONPRC) monkeys were monitored for menses into the third 
year on CR.  Table 2.9 shows the distribution of regular and irregular cyclers of 
the old short-term (ONPRC) monkeys.  Previously determined (based on 90 day 
hormone data; Table 2.3) numbers of regular and irregular cyclers are indicated 
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in parentheses.  The relative number of irregular cyclers in the OCR group 
increased (from 2 of 7 to 5 or 7) while the number of irregular cyclers in the 
OCON group remained the same (3 of 8).   
Table 2.9  Distribution of Regular and Irregular Cyclers in the Old Short-
Term (ONPRC) Group in Year 3.  Using Gilardi and colleagues’ (Gilardi et al., 
1997) definition for regular and irregular cyclers, menses records were used to 
evaluate menstrual cyclicity in the third year on CR.  Parenthesized numbers 
indicate regular and irregular cycler numbers as determined after 1-2 years on 
CR (Table 2.3).  
ONPRC  Regular Cyclers Irregular Cyclers Total 
OCON 4 (5) 3 (3) 7 (8) 
OCR 2 (5) 5 (2) 7 (7) 
 
DISCUSSION: 
Menopause is not strictly a reproductive issue.  Its effects cross over into 
other areas of health and well-being, including cognitive, skeletal and 
cardiovascular systems (Johnson et al., 2004; Nappi et al., 1999; Prior, 1998; 
Sherwin, 2003).  Therefore, the need to find an appropriate model in which to 
study this inevitable life event is extremely relevant and emergent.  Furthermore, 
the development of potential interventions (i.e. calorie restriction) by which to 
delay menopause would be extraordinarily beneficial.  
 
The Rhesus Monkey as a Model for Menopause 
 The hypothalamic-pituitary axis and the ovary act in concert to regulate all 
facets of female reproduction.  At the time of reproductive decline, the hormones 
released by these feedback circuits are disrupted.  Although FSH is elevated and 
INHB is reduced in women (Klein et al., 1996a; Soules et al., 1998), little 
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research has been performed investigating the endocrine patterns of peri-
menopause in rhesus monkeys. 
Researchers have recommended the use rhesus monkeys as an 
appropriate animal model for studying menopause (Bellino and Wise, 2003; 
Heape, 1900).  Previous reports have also shown that like women, menopause in 
rhesus monkeys is associated with amenorrhea, low urinary estrone conjugates  
(which are metabolites of circulating estrogens), and irregular patterns of urinary 
pregnanediol-3 glucuronide (progesterone metabolites; (Gilardi et al., 1997).  
Using trained monkeys, we were able to collect serum over the course of 
approximately 90 consecutive days and confirmed similar changes to those 
observed in women: the absence of mid-cycle E2 peaks and the accompanying 
luteal phase, in older females.  Older, peri-menopausal monkeys also displayed 
irregularly timed menses intervals. 
Shideler, and colleagues (Shideler et al., 2001) reported that urinary FSH 
levels were elevated in menopausal rhesus monkeys only after menstrual 
irregularities were noted.  These data were surprising given that in women, FSH 
is one of the first detectable signs of reproductive decline.  Our data collected 
from the ONPRC colony provides the first evidence that rhesus monkeys do in 
fact have elevated FSH levels prior to exhibiting irregular menstrual cycles, with 
FSH in Y monkeys lower than OR.    Surprisingly, OI monkeys had FSH levels 
similar to Y and less than OR monkeys.  There are a couple of possible 
explanations for these observations.  It may be that after a period of elevated 
FSH levels without appropriate ovarian response, the pituitary halted FSH 
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production in the OI females.   Alternatively, it may have been due to stress-
related shut down in the hypothalamic pituitary gonadal axis.   
In the NIA monkeys, FSH levels were also lower among the Y as 
compared to O monkeys; however, there was no difference between FSH levels 
between Y and OR monkeys.  This is likely due to the fact that the O monkeys in 
the NIA colony are on average 2-3 years younger than the ONPRC colony.  
During the peri-menopause a difference of a few years may be critical and 
sensitive time for hormone changes.  As expected, however, OI monkeys 
displayed elevated FSH levels and were significantly different from both Y and 
OR monkeys.  
INHB levels reflected the hormone changes that paralleled FSH.   
Interestingly, we observed a slight difference in the pattern of hormone 
distribution between the Y, OR and OI groups with INHB as compared to our 
FSH results.  The INHB data were in fact more consistent with predicted changes 
in that Y monkeys exhibited the highest levels of INHB; OI monkeys had the 
lowest levels and OR monkeys were intermediate.  The difference between the 
two hormones may be explained by the temporal relationship of the hormone 
changes.  That is, our data are consistent with data from peri-menopausal 
women that suggest that changes in INHB occur not only prior to menstrual cycle 






Calorie Restriction and Menstrual Cycling 
 Nutrition and reproduction are exquisitely interconnected.  Both anorexia 
and obesity can have detrimental effects on reproduction, inhibiting both menses 
and fertility (Bray, 1997; Messinis and Milingos, 1999; Misra et al., 2004).  
Moderate CR, is a well known nutritional intervention that extends overall life 
span in many species.  Effects of CR on reproduction and reproductive life span 
have in rodents have yielded mixed results.  This study is also the first to 
evaluate semi-longitudinal menstrual cycling in monkeys maintained on a CR 
diet.  A single study showed similarities in E2 and FSH between CON and CR 
rhesus monkeys (Black et al., 2001), however in this study, only samples 
collected on Menses day 5 were assayed in these  comparisons.   
Our data were carefully collected and monkeys were trained to the blood 
sampling protocol to remove the necessity for anesthesia and to reduce stress.  
After analyzing the hormone levels collected during the 90 day sampling periods, 
we conclude that 30% CR is not detrimental to normal menstrual cycling either in 
short- or long-term protocols.  We found no differences between regularly cycling 
monkeys in LH, FSH, E2, P4, or INHB (relative to the LH peak) within age groups 
in either the long- or short-term CR animals.  Even in the potentially more 
sensitive FSH and INHB analyses (Menses d1 through d5), CON and CR results 
were similar and therefore did not detect any deleterious effects of CR. 
 Both the short-term (ONPRC) and long-term (NIA) colonies were 
maintained on moderate levels of calorie restriction, with supplementation for 
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vitamins and minerals.  These monkeys are restricted, but not malnourished.  
Therefore, we conclude from theses data, that this permits normal functioning of 
the reproductive axis.  Furthermore, given the comparison between hormone 
profiles within the OR and OI groups, all the females are transitioning into the 
peri-menopause similarly.  Whether moderate CR in rhesus monkeys will be able 
to delay menopause remain to be seen, however we can be confident that this 
level of nutritional intervention does not appear to be harmful to reproductive 
function in young monkeys. 
 Finally, in evaluating the menses records collected from the short-term 
(ONPRC) old females, we found that by year 3, changes in the relative numbers 
of irregular cyclers increased.  There may be due to a trend for more monkeys to 
enter into peri-menopause in the short-term (ONPRC) CR group relative to CON.  
This may be a indication of advancement into peri-menopause by the CR group.  
The long-term (NIA) group of monkeys has been maintained on CR for 11-12 
years, far longer than the short-term (ONPRC) group and yet we did not detect 
any difference between the Old monkeys.  Initiation of CR later in life may not 
show detriments within the first couple of years, but later demonstrated signs of 
impaired ovarian function.  The long-term (NIA) old monkeys are several years 
younger than the short-term (ONPRC) group; thus, it may be necessary to wait to 
determine if there will be similar changes and/or possible detriments to 






 Menopause is universally relevant, affecting all women at some point in 
their lives.  Along with reduced fertility, menopause brings with it, many other 
physiological health risks.  Despite the significance of this life event, little is 
known about the initiating triggers for menopause. 
Our data provide extremely useful information with regard to the use of 
rhesus monkeys in menopause research.  We have confirmed previous reports 
that rhesus monkeys exhibit similar menstrual cycles (approximately 28 days in 
length), and hormone profiles in young, regularly cycling animals.  Additionally, 
we report for the first time that rhesus monkeys display reduced levels of INHB 
and elevated levels of FSH prior to menstrual cycle irregularities, similar to 
women.  These data further confirm the suitability of the rhesus monkey model in 
ovarian aging research.  
Finally, we demonstrated that moderate calorie restriction is not 
detrimental to normal ovarian cyclicity in young females.  Initiation of moderate 
CR in old females, under short-term conditions, may have no impact within the 
first 1-2 years; however, some detrimental effects were observed after 3 years on 
the treatment in these old monkeys.  There is a trend to advance cycle 
irregularity among old short-term (ONPRC) females.  Long-term (NIA) old CR 
monkeys appear to be going through the normal progression of ovarian aging.  
This group of monkeys is several years younger and we will have to wait to see if 
they continue to function similarly to the old CON, or if they also begin to show 
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advanced signs of menstrual cycle irregularity.  Furthermore, we are currently 
reviewing menses records to evaluate these females over the course of the full 
year, and not simply the 90-day period in which we collected samples.   
It is therefore possible to pursue other possible benefits of CR without 
compromising reproductive function in young females.  Young female rhesus 
monkeys continue to cycle normally on the nutritional protocol (both long- and 
short-term).  To date, the long-term (NIA) older monkeys are displaying normal 
age-related hormonal changes as well.  Given our results in the short-term 
(ONPRC) old monkeys, considerations must be made with regard to animal age 
at CR initiation and duration of the treatment. 
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Figure 2.1 Short-Term (ONPRC) Regular Cyclers.  Representative estradiol 
(E2) and progesterone (P4) graphs for 3 consecutive menstrual cycles.  Profiles 
of regular cyclers (≥2 cycles demonstrating a mid-cycle E2 peak followed by 
luteal phase levels of P4) are depicted above: A) Young CON, B) Young CR, C) 









































































































Figure 2.2 Short-Term (ONPRC) OCON Irregular Cyclers.  Individual estradiol 
(E2) and progesterone (P4) graphs for approximately 90 days.  Profiles of old 
CON irregular cyclers (OI-CON) are depicted above.  Onset of menses indicated 
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Figure 2.3 Short-Term (ONPRC) OCR Irregular Cyclers.  Individual estradiol 
(E2) and progesterone (P4) graphs for approximately 90 days.  Profiles of old CR 
irregular cyclers (OI-CR) are depicted above.  Onset of menses indicated by “M.”  
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Figure 2.4 Short-Term CR (ONPRC) Hormone Profiles Relative to 
Each graph represents the hormone levels averaged for each female 
regular cycles across three consecutive cycles and normalized to the 
mid-cycle LH peak (d=0).  All YCON (n=5) and YCR (n=5) were include
of 8 OCON and 3 of 8 OCR were included.  A) Luteinizing hormone
follicle-stimulating hormone (FSH); C) estradiol (E2); D) progesterone
E) inhibin B (INHB).  
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Figure 2.5 Short-Term (ONPRC) FSH Relative to Onset of Menses.  Follicle-
stimulating hormone (FSH) levels averaged for each female across the three 
consecutive cycles (or approximately 90 days) and normalized to the onset of 
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Figure 2.6 Short-Term (ONPRC) INHB Relative to Onset of Menses.  Inhibin 
B (INHB) levels averaged for each female across the three consecutive cycles 
(or approximately 90 days) and normalized to the onset of menses or nadirs 
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Figure 2.7 Long-Term (NIA) Regular Cyclers.  Representative estradiol (E2) 
and progesterone (P4) profiles of regular cyclers on long-term CR (NIA).  Profiles 
of regular cyclers (≥2 cycles demonstrating a mid-cycle E2 peak followed by 
luteal phase levels of P4) are depicted above: A) Young CON, B) Young CR, C) 











































































































Figure 2.8 Long-Term (NIA) OCON Irregular Cyclers. Individual estradiol (E2) 
and progesterone (P4) graphs for approximately 90 days.  Profiles of old CON 
irregular cyclers (OI-CON) are depicted above.  Onset of menses indicated by 













































































































































Figure 2.9 Long-Term (NIA) OCR Irregular Cyclers.  Individual estradiol (E2) 
and progesterone (P4) graphs for approximately 90 days.  Profiles of old CR 
irregular cyclers (OI-CR) are depicted above.  Onset of menses indicated by “M.”  
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Figure 2.10 Long-Term (NIA) Hormone Profiles Relative to LH Peak.  Each 
graph represents the hormone levels averaged for each female exhibiting regular 
cycles across three consecutive cycles and normalized to the estimated mid-
cycle LH peak (d=0).  All YCON (n=5) and YCR (n=7) were included while 3 of 6 
OCON and 1 of 5 OCR were included.  A) Luteinizing hormone (LH); B) follicle-
stimulating hormone (FSH); C) estradiol (E2); D) progesterone (P4) and E) 
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Figure 2.11 Long-Term (NIA) FSH Relative to Onset of Menses.  Follicle-
stimulating hormone (FSH) levels averaged for each female across the three 
consecutive cycles (or approximately 90 days) and normalized to the onset of 
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Figure 2.12 Long-Term (NIA) INHB Relative to Onset of Menses.  Inhibin B 
(INHB) levels averaged for each female across the three consecutive cycles (or 
approximately 90 days) and normalized to the onset of menses or nadirs 




OVARIAN RESERVE TESTS AND THEIR UTILITY IN PREDICTING 
RESPONSE TO CONTROLLED OVARIAN STIMULATION 
IN RHESUS MONKEYS 
 
INTRODUCTION: 
Considering the high price of assisted reproduction, it is considered 
prudent to estimate the probability of success prior to costly follicle stimulation 
and in vitro fertilization (IVF) protocols.  Ovarian reserve tests (ORTs) are used to 
give a relative measurement of the remaining follicular pool.  ORTs have become 
more commonplace in human clinics to assist in counseling patients with regard 
to chances of pregnancy success with or without exogenous hormone treatment.    
The monotropic rise in follicle-stimulating hormone (FSH) is often considered to 
be the hallmark event associated with declining fertility.  Conversely, 
comparisons between young and peri-menopausal women have showed reduced 
levels of inhibin B (INHB).  Of note is the fact that these hormonal changes occur 
prior to any measurable change in estradiol, progesterone or luteinizing hormone 
(Klein et al., 1996).  
Marked advances have been made using ORTs, in human research, with 
far less study using their animal model counterparts.  Primarily, development of 
ORTs in nonhuman primate models would make it possible to identify the best 
animals for future research in artificial reproductive technologies.  Secondarily,  
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controlled ovarian stimulation (COS) and in vitro fertilization are frequently an 
unavoidable alternative to natural breeding when animals are geographically 
isolated or are behaviorally incompatible.  Finally, there is a great need to identify 
nonhuman primates entering menopause for basic aging research.  
Unfortunately, ART breeding programs can be expensive and sometimes require 
moderately invasive animal procedures, with no guarantee of success.  
Therefore, use or ORTs could assist in focusing resources on animals with the 
best likelihood of successful pregnancies.   
Early follicular phase FSH (day 3) has been shown to correlate well with 
ovarian reserve.  Measurement of basal FSH alone, while extremely useful, can 
be somewhat variable.  Thus, a number of tests have been developed that when 
used in conjunction with basal FSH levels, have been successful in predicting 
ovarian response.  In general, most of these tests rely on assessing hormonal 
response to ovarian stimulation, whether at the level of the hypothalamus, 
pituitary or direct action on the ovary.   
Fanchin et al. (Fanchin et al., 1994) recently developed a supplemental 
protocol to the standard FSH measurements to assess ovarian reserve.  The 
exogenous follicle stimulating hormone ovarian reserve test (EFORT) 
significantly improved the predictive value of basal FSH alone for IVF response.  
Subjects were injected with purified FSH on cycle day 3; blood was drawn prior 
to and 24 hours after FSH administration.  Concomitant analysis of basal FSH 
and change in E2 following treatment was found to be effective in differentiating  
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between good and poor responders to IVF.  Change in INHB following EFORT, 
has also been shown to correlate well with response to IVF (Dzik et al., 2000).   
Women with both low baseline INHB levels as well as reduced INHB response to 
EFORT were less responsive to IVF treatment.   
The clomiphene citrate challenge test (CCCT) is a similar and also highly 
effective test of ovarian reserve.  CCCT has been proven to be 93% effective in 
predicting infertility and was more successful in identifying low ovarian reserve 
patients than basal FSH alone (Kahraman et al., 1997).  In young, healthy 
ovaries, ovarian reserve may be associated with an ample number of developing 
follicles.  Administration of clomiphene citrate (CC), a hypothalamic estradiol 
receptor blocker, results in up-regulation of FSH and LH from the pituitary.  
Clomiphene citrate is an orally active non-steroidal chemical that is a mixture of 
two isomers: zuclomiphene and euclomphene; zuclomiphene being more active 
of the two (Speroff et al., 1999).  Clomiphene itself, is weakly estrogenic; 
however, due to its ability to bind receptor for long periods of time, results in 
reduced negative feedback and increased gonadotropins, likely via activation of 
GnRH secretion. This stimulates follicular growth and subsequent production of 
inhibin and estradiol (Speroff et al., 1999).  In the case of a peri-menopausal 
ovary, reduced follicle number results in a reduced inhibin response and 
presumably reduced negative feedback at the level of the pituitary and/or 
hypothalamus.  In human clinical trials, the CCCT is commonly used in 
conjunction with day 3 (with onset of mense as day 1 of the menstrual cycle)  
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FSH levels to predict relative ovarian reserve.  Patients are hormonally monitored 
to determine cyclicity, using P4 and LH.  Basal FSH and E2 are measured in 
early follicular phase (days 2-5) and 100 mg clomiphene citrate is administered 
orally once daily in mid follicular phase (days 5-9).  FSH and E2 are measured in 
late follicular phase (days 9-11).  The results of the basal versus clomiphene 
citrate-stimulated FSH and E2 may be used to predict relative IVF success.  
Cessation of CC results in suppression of FSH, likely via endogenous ovarian 
inhibins.  INHB may be measured in combination with the CCCT as a direct 
measure of ovarian responsiveness.  It has been shown that women with normal 
ovarian reserve have higher granulosa cell INHB production as compared with 
women with diminished ovarian reserve (Hofmann et al., 1998).  Thus, the results 
of the CCCT are evaluated considering that younger women will a large ovarian 
reserve respond to CCCT with a dramatic change in estradiol, comparing basal 
to stimulated hormone levels.  Older women with significantly reduced ovarian 
reserve respond to CCCT with little to no change in estradiol, when comparing 
basal to stimulated hormone levels. 
The first detectable hormone changes are measurable in women years 
before the final climacteric (Robertson and Burger, 2002; Santoro, 2005).  Thus 
the potential for a menopause delaying regimen would be extremely beneficial.  
In rats, moderate calorie restriction (CR) has been shown to be an effective 
method of delaying the onset of ovarian decline (Holehan and Merry, 1985c; 
Merry and Holehan, 1979).  Results were somewhat mixed in mice maintained 
on moderate CR (with regard to onset of puberty), although delayed ovarian 
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decline was confirmed (Nelson et al., 1985).  Preliminary results in rhesus 
monkeys suggest that animals continue to cycle normally (Wu et al., 2004), 
however, further research must still be performed. 
The objective of this study was two-fold.  We evaluated several commonly 
used clinical ORTs and hormone indices, to predict response to controlled 
ovarian stimulation in rhesus monkeys.  These included: day 3 (d3) follicle-
stimulating hormone (FSH), day 3 inhibin B (INHB); the clomiphene citrate 
challenge test (CCCT); and the exogenous follicle-stimulating hormone test 
(EFORT).  Additionally, we used those ORTs to assess the effect of moderate 
CR in these animals.  This study is the first to evaluate the use of ORTs in 
nonhuman primates and offers valuable information to both clinical, laboratory 
and captive settings alike. 
 
Materials and Methods 
Animals and Diet 
Female rhesus monkeys (Macaca mulatta) were identified for this study 
and maintained on a control diet ad libitum to determine average daily feed 
intake (AFI).  AFI was then divided into two meals and control (CON) monkeys 
received the full amount, while calorie restricted (CR) monkeys were reduced by 
10% each month until the desired 30% CR was achieved.  Young (Y; 12 years) 
and old (O; 19-26 years) monkeys were distributed as follows: YCON, n=4; YCR, 
n=4; OCON, n=9; OCR, n=5.  
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The diet has been described in detail by Lane et al., 2001 and represents 
restricted intake of a nutritionally replete diet.  A 30% calorie restriction is 
considered moderate, and the animals appear to continue to cycle normally.   
 
Ovarian Reserve Tests 
All monkeys were monitored for onset of menses (d=1), and several 
clinically used ovarian reserve tests (ORTs) were evaluated for diagnostic 
accuracy in predicting response to controlled ovarian stimulation (COS) in rhesus 
monkeys.  The ORTs included: day 3 follicle-stimulation hormone (FSH), day 3 
inhibin B (INHB), the clomiphene citrate challenge test (CCCT) and the 
exogenous FSH ovarian reserve test (EFORT).  ORT predictions were 
retrospectively compared to a controlled ovarian stimulation (COS) to determine 
prediction accuracy.  
Blood samples were collected from the saphenous vein in trained 
monkeys with no anesthesia.  Serum was then stored at -20˚C until assayed.  
Samples were assayed for estradiol (E2) and FSH at the Oregon National 
Primate Research Center (ONPRC) Endocrine CORE.   
Inhibin B was determined using the commercially available Active Inhibin 
B kit (Diagnostic Systems Laboratory; Webster, TX).  This ELISA was validated 
for use with rhesus monkey serum in our laboratory.  Parallel displacement 
curves were obtained by comparing serially diluted (1:1 to 1:16) pooled rhesus 
monkey serum against known INHB concentrations.  Recovery of known 
concentrations of unlabeled INHB added to pooled rhesus monkey serum was 
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100% with a coefficient of variation of 10%.  Inter-assay coefficients of variation 
for two internal controls were 15% and 9%.  The intra-assay coefficient of 
variation was always less than 10%.   
 
Ovarian Reserve Tests 
Mean ± SE hormone levels were similar between diet groups within ages 
and COS outcome.  Therefore, subsequent analyses grouped CON and CR.  
ORTs were evaluated based on individual hormone responses and COS 
outcome was retrospectively used to classify OCON and OCR into successful or 
unsuccessful COS (COS+/-).  Chi-square analyses were then performed to 
evaluate ORT predictions relative to actual COS outcomes.   
  
Day 3 FSH 
During a spontaneous menstrual cycle, serum FSH was determined on 
day 3 (d3; menses=d1).  Based on human clinical data, elevated early follicular 
phase FSH has been shown to indicate reduced ovarian reserve and 
consequently reduced COS response.  D3 FSH values were used to predict COS 
outcome (successful, COS+ and unsuccessful, COS-) as follows: 
 
 
Table 3.1 D3 FSH Criteria for Predicting COS Outcome.  Criteria for prediction 
outcome following controlled ovarian stimulation (COS).  Day 3 follicle-stimulating 
hormone (FSH; menses = day 1) less than or equal to 1.0 ng/mL predicts a 
successful COS (COS+); Day 3 FSH greater than 1.0 ng/mL predicts an 
unsuccessful COS (COS-).   
Hormone Criteria Prediction
≤ 1.0 ng/mL COS+ d3 FSH 
> 1.0 ng/mL COS- 
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Day 3 INHB 
During a spontaneous menstrual cycle, serum INHB was determined on 
d3.  Inhibin B levels are inversely related to FSH levels and reduced INHB levels 
have been shown to indicate poor ovarian reserve and reduced COS response.  
D3 INHB levels were used to predict COS outcome as follows: 
Table 3.2 D3 INHB Criteria for Predicting COS Outcome.  Criteria for 
prediction outcome following controlled ovarian stimulation (COS).  Day 3 inhibin 
B (INHB; menses = day 1) greater than or equal to 50 pg/mL predicts a 
successful COS (COS+); d3 INHB less than 1.0 ng/mL predicts an unsuccessful 
COS (COS-). 
Hormone Criteria  Prediction
≥ 50 pg/mL COS+ d3 INHB 
< 50 pg/mL COS- 
 
CCCT 
During a spontaneous menstrual cycle, 50 mg clomiphene citrate was 
administered orally on d5-d9 and serum FSH, E2 and INHB were determined on 
d3 and d10 (Figure 1).  Clomiphene citrate is believed to act by blocking estrogen 
receptors at the level of the hypothalamus and/or pituitary.  Reduced feedback at 
these tissue sites results in the stimulation of gonadotropins and increased 
stimulation at the level of the ovary.  In a young female, the ovary contains a 
large cohort of developing follicles; therefore, it will respond to increased levels of 
gonadotropins with an amplified production of ovarian hormones.  Consequently, 
gonadotropin production would perceive higher levels of ovarian hormones and 
inhibit production of gonadotropins.  Therefore, clinicians expect to see increased 
levels of E2 and reduced levels of FSH in women with a large ovarian reserve.  
Conversely, a woman with poor ovarian reserve would respond with low levels of 
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E2 and high or unchanged levels of FSH.  Standard CCCT predicts COS 
outcome based on d3 and d10 FSH changes alone.  We evaluated INHB and E2 
changes as well.  CCCT hormone changes were used to predict COS outcome 
as follows: 
Table 3.3 CCCT Criteria for Predicting COS Outcome.  Criteria for prediction 
outcome using the clomiphene citrate challenge test (CCCT) following controlled 
ovarian stimulation (COS) using either follicle-stimulating hormone (FSH) or 
inhibin B (INHB) alone; or in combination with fold change in Estradiol (E2).  
Hormone 1 Criteria 1 Hormone 2 Criteria 2 Prediction
d3 and d10 FSH ≤ 1.0   COS+ 
d3 and/or d10 FSH > 1.0   COS- 
> 1.0 d10 E2 > 2 fold COS+ d3 FSH 
> 1.0 d10 E2 > 2 fold COS- 
d3 and d10 INHB ≥ 50 pg/mL   COS+ 
d3 and/or d10 INHB < 50 pg/mL   COS- 
≥ 50 pg/mL d10 E2 > 2 fold COS+ d3 INHB 
 < 50 pg/mL d10 E2 > 2 fold COS- 
 
EFORT 
During a spontaneous menstrual cycle, Antide (Ares Serono; 0.5 mg/kg 
BW subcutaneous, at 0800) and recombinant human FSH (r-hFSH; Gonal-F; 
Ares Serono; 30 IU; intramuscular at 0800 and 1700) was administered.  Whole 
blood was collected from the saphenous vein just prior to (d1) and approximately 
24 hours following (d2) the first injection of r-hFSH.  Fold change in E2, FSH and 
INHB was used to predict COS outcome and diagnostic accuracy was 









Table 3.4 EFORT Criteria for Predicting COS Outcome.  Exogenous Follicle-
Stimulating Hormone Ovarian Reserve Test (EFORT) criteria for predicting COS 
outcome using fold change in Estradiol (E2), Follicle-Stimulating Hormone (FSH) 
or Inhibin B (INHB). 
Hormone Criteria Prediction 
≥ 1.5 fold change in d1 E2 COS+ d2 E2 
< 1.5 fold change in d1 E2 COS- 
≥ 1.5 fold change in d1 FSH COS+ d2 FSH 
< 1.5 fold change in d1 FSH  COS- 
≥ 1.5 fold change in d1 INHB COS+ d2 INHB 
< 1.5 fold change in d1 INHB COS- 
 
COS  
In a spontaneous menstrual cycle, Antide (Ares Serono; 0.5 mg/kg BW, 
sc, at 0800h) was administered on d1-d9 to inhibit endogenous gonadotropin 
production and recombinant human FSH (r-hFSH; (Gonal-F; Ares Serono; 30 IU 
intramuscularly at 0800 and 1700) was administered on d1-d6 followed by r-
hFSH + r-h luteinizing hormone (Lahdi; Ares Serono; im, at 0800) on d6-d9 to 
stimulate the production of multiple preovulatory follicles.  This was followed by 
an injection of h-chorionic gonadotropin (Serono; 1000 IU, im) on d10 or d11 to 
induce ovulatory maturation.  Trans-abdominal ultrasonography was performed 
on d7 to confirm the presence of a minimum of 3 follicles of 4mm diameter on 
each ovary.  Blood samples were also collected daily from the saphenous vein 
and E2 levels were determined to indirectly assess follicular response. As part of 
a separate experiment, follicle aspiration via laparoscopy was performed 27 h 
following the r-hCG injection.  COS was classified as either successful (COS+) or 





Table 3.5 COS Criteria for Outcome.  Controlled Ovarian Stimulation (COS) 
criteria for classifying a successful (COS+) or unsuccessful (COS-) response. 
Hormone Criteria Ultrasound Criteria Outcome 
> 1000 pg/mL > 3 follicles of 4 mm diameter / ovary COS+ peak E2 
< 600 pg/mL < 3 follicles of 4 mm diameter / ovary COS- 
 
Hormone Assays: 
Monkeys were monitored for onset of menses (designated Menses d1).  
Serum was collected from the saphenous vein for 3 cycles (or approximately 90 
days) following a spontaneous menses: daily during the follicular phase and 
every third day during the luteal phase.  Circulating hormones were assayed for 
estradiol (E2) by specific electrochemoluminescent assay using a Roche Elecsys 
2010 assay instrument at the Endocrine Services Laboratory Core, ONPRC 
(Beaverton, OR).  Follicle-stimulating hormone (FSH) was determined using an 
in-house radioimmunoassay (RIA).  Hormone concentrations were validated 
against previous RIAs in this laboratory (Hess et al., 1981; Zelinski-Wooten et al., 
1995). 
Inhibin B was determined using the commercially available Active Inhibin 
B kit (Diagnostic Systems Laboratory; Webster, TX).  This ELISA was validated 
for use with rhesus monkey serum in our laboratory.  Parallel displacement 
curves were obtained by comparing serially diluted (1:1 to 1:16) pooled rhesus 
monkey serum against known INHB concentrations.  Recovery of known 
concentrations of unlabeled INHB added to pooled rhesus monkey serum was 
100% with a coefficient of variation of 10%.  Inter-assay coefficients of variation 
for two internal controls were 15% and 9%.  The intra-assay coefficient of 




Descriptive statistics were conducted using SAS Statistical software (Cary, 
NC).  For each ORT we examined the relationship between individual hormone 
measurements and COS outcome.  Number of correct and incorrect predictions 
(% accuracy) for each ORTs was determined overall for young and old monkeys.  
Chi-square analyses were performed to evaluate categorical data with ORT 
predictions compared to actual COS results.  Significance was determined at p < 
0.05.    
 
RESULTS: 
Calorie Restriction and the ORTs 
Results were similar between control and CR monkeys at each age group 
and COS classification.  Figures 3.1A and B show the mean ± SE for d3 FSH 
and INHB levels, respectively, for YCON, YCR, OCON (COS+/-) and OCR 
(COS+/-).  As expected, Young monkeys exhibited lower FSH and higher INHB 
levels as compared to old monkeys.  Figures 3.1C and D show the mean ± SE 
for the CCCT using FSH and INHB levels, respectively, for YCON, YCR, OCON 
(COS+/-) and OCR (COS+/-).  Figures 3.1E, F and G show the mean ± SE for 




 Figure 3.2 A and B provide the individual d3 FSH values for young and old 
monkeys, respectively with COS outcome listed.  Figure 3.2C shows the ratios of 
correct to incorrect predictions of CO response.  Using the listed criteria for d3 
FSH alone, we found an overall 59% accuracy in predicting COS outcome.  Day 
3 FSH predictions, however, were significantly different (p < 0.01) from the actual 
COS outcomes.    
       
d3 INHB 
 As anticipated, d3 INHB levels were significantly lower in old as compared 
to young monkeys, with no diet effects.  Figures 3.3A and B reveal the individual 
d3 INHB values for young and old monkeys, respectively, with COS outcome 
indicated.  Figure 3.3C shows the distribution of correct and incorrect predictions 
of COS outcome based on the d3 INHB criteria described above.  Overall, d3 
INHB was 77% accurate in predicting COS outcome.  Day 3 INHB predictions, 
were found to be similar (p > 0.01) to actual COS outcomes.    
 
CCCT 
 A number of hormone markers were evaluated in conjunction with 
administration of CCCT.  Figures 3.4A and B show the individual change in FSH 
with CCCT.  Figure 3.4C shows the ratio of correct to incorrect predictions.  
Using FSH with the CCCT, we found a 45% accuracy in predicting COS outcome 
which is lower than using d3 FSH alone (59%).  Figures 3.5A and B demonstrate 
the individual change in INHB with CCCT.  Figure 3.5C shows the number of 
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correct and incorrect COS outcome predictions.  CCCT with INHB was 59% 
accurate which was also lower than d3 INHB alone (77%).  Predictions using 
CCCT with FSH or INHB were both significantly different (p < 0.01) from the 
actual COS outcomes.      
Modifying the CCCT to include a second hormone, E2 improved both FSH 
and INHB prediction accuracy to 77% and 82%, respectively.  Figure 3.6A 
presents the fold change in E2 following CCCT.  E2 values were consulted after 
using d3 FSH or d3 INHB.  COS- predictions were then confirmed or refuted, 
based on fold change in E2.  Predictions made using the modified CCCT with 
both FSH and INHB were found to be similar (p > 0.01) to actual COS outcomes.    
 
EFORT 
 E2, FSH and INHB were evaluated in conjunction with the EFORT.  
Figures 3.7A and B indicate the individual changes in E2 following the EFORT 
and the overall accuracy of the hormone in predicting COS outcome (65%).  
Figures 3.8A and B depict the individual changes in FSH following the EFORT 
and the overall prediction accuracy for FSH (55%).  Figures 3.9A and B show the 
individual fold change in INHB following EFORT, with a prediction accuracy of 
80% (Figure 3.6C).  Only predictions made by EFORT using INHB were found to 




 Table 3.6 presents the distribution of COS outcome.  All young monkeys 
had a successful COS (COS+), regardless of diet.  Four out of nine (44%) OCON 
and three out of five (60%) of OCR monkeys had a COS+.  Figure 3.10A is a 
representative profile of a COS+; and Figure 3.10B is a representative profile of a 
COS-.  Accompanying ultrasounds are also presented.  . 
 
DISCUSSION: 
Elevated FSH is often considered the hallmark effect of ovarian aging and 
is commonly used in clinical practices to make medical decisions with regard to 
both pregnancy and/or menopause.  With the development of the INHB assay, 
various reports have suggested that INHB may actually be a more sensitive 
index for ovarian function and reserve (Klein et al., 1998; Santoro, 2005; Soules 
et al., 1998).  Despite the publication of such reports, INHB levels are still not as 
widely used as FSH in clinical settings (Klein et al., 2004; Robertson and Burger, 
2002; Welt et al., 1999). 
Our data consistently find INHB to be superior to FSH in predicting COS 
outcome, regardless of ORT (Table 3.7).  In fact, our results show that the best 
diagnostic test for predicting COS outcome was the CCCT using INHB values in 
conjunction with fold change in E2 (82%).  These results are in agreement with 
human studies that have shown INHB to be better than FSH in predicting 
response to follicle stimulation.  Figure 3.11 shows a flow chart depicting the 
modified CCCT with INHB.   
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Anti-mullerian hormone (AMH) has recently been suggested as another 
quality indicator of ovarian reserve (van Rooij et al., 2002; Visser et al., 2006).  
AMH is produced by the granulosa cells and may be measured in serum (Al-
Qahtani et al., 2005; Tremellen et al., 2005).  There are limited data evaluating 
AMH as a potential ORT in women; however, it has not yet been validated in 
nonhuman primates (Penarrubia et al., 2005; Themmen, 2005).    
This is the first report using and comparing ORTs in monkeys.  We 
evaluated the hormonal response to the selected ORTs in both young and old, 
and control and CR-fed monkeys.  There were no differences between groups.  
Similar findings were reported by our group when analyzing menstrual cycling 
data (Wu et al., 2004).  Although we have yet to determine the effects of CR on 
delaying menopause, we believe that 30% CR does not inhibit normal ovarian 
function.  Furthermore, based on the results from the ORTs, we would not 
anticipate any differences with COS between the groups.   
 
Ovarian Reserve Tests 
We were surprised to find that both d3 FSH and d3 INHB alone had better 
predictive value as compared to the CCCT.  A couple of obvious factors may be 
contributing.  Clomiphene citrate has a bitter flavor and unlike with human 
patients, it must be mixed or hidden in a food source when administered to 
monkeys.  With finicky eaters compliance is difficult to assure, even in a 
laboratory setting.  Secondly, the level of clomiphene citrate we used was based 
on an initial study in which older animals were tested for their response to the 
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drug (data not shown).  Among the young animals, there were several animals 
where INHB and/or E2 levels dropped precipitously and unexpectedly after 
administration of the drug.  This could be attributed to stress or more likely, an 
endocrine response to a high level of stimulation.   
Lupron (leuprolide acetate) is a GnRH agonist in the short-term, but is 
often used to inhibit endogenous production of GnRH due to its ability to shut 
down hypothalamic production of the hormone with continuous application 
(Badaru et al., 2006).  In future studies, we may need to consider titration of 
clomiphene citrate with different doses at different ages.  In a younger animal, 
levels of clomiphene citrate that are too high may result in the reverse of the 
desired effect: inhibition rather than stimulation of pituitary and ovarian 
hormones. 
Marut and Hodgen (Marut and Hodgen, 1982) also observed declining 
levels of E2 in monkeys administered 25 mg clomiphene citrate daily for 5 days, 
despite elevated levels of FSH.  The authors suggested that clomiphene citrate 
acted in an anti-estrogenic fashion, imparting ovarian refractoriness.  Our doses 
of clomiphene citrate were higher (50 mg daily for 5 days) and we did not 
observe this same hormone pattern consistently, rather only in select females.  
This finding further underlines the need to titrate appropriate dosages of 
clomiphene citrate.    Although clomiphene citrate is believed to act by blocking 
estrogen receptors, the exact mechanism of action is not fully understood.  
Perhaps in future studies a pure estrogen antagonist would provide more 
consistent results.  With regard to the continued use of the CCCT in rhesus 
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monkeys, however, use of multiple hormones (day 3 INHB pre-screen and fold 
change in E2) greatly improves the prediction accuracy of the ORT.    
EFORT with INHB showed a predictive accuracy of 80%, very close to the 
CCCT with INHB.  The major advantage to the EFORT is timing.  Using the INHB 
kit (DSL, Webster, TX), hormone assay results are possible within 24 hours.  
Therefore, the EFORT may be performed with plans to convert to a full COS 
conditionally, based on the results of the EFORT.  This would combine both the 
ORT and COS into one cycle.  Additionally, the EFORT may provide an 
advantage in situations where oral medication is precluded and injections may be 
logistically more practical. The primary disadvantage to this method is financial.  
Should the EFORT predict a COS- the hormone injections would be purely 
diagnostic.  The cost of FSH injections is not trivial and must be weighed against 
the risk of waiting, especially when dealing with older or genetically valuable 
animals. 
The results for d3 INHB alone cannot be ignored, however, even with the 
lower prediction accuracy of 77%.  As explained previously, clomiphene citrate 
has an offensive taste and may be difficult to administer in captive or zoo 
settings.  Furthermore, d3 INHB requires only a single blood sample.  We were 
not entirely surprised to find that INHB was more accurate than FSH in predicting 
COS outcome.  This has been shown in human data as well (Danforth et al., 
1998; Klein et al., 1996c; Welt et al., 1999).  INHB is an ovarian hormone and 
may be considered a more direct measure of ovarian function than pituitary FSH.  
Measurement of INHB also has some advantages; INHB enzyme-linked 
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immunosorbant assay (ELISA) kits are commercially available and relatively easy 
to perform.  Furthermore, there are currently only two manufacturers of the INHB 
ELISA and they both use the same set of standards.  Therefore, INHB values 
may be easily compared between laboratories.  
 For rhesus monkeys, the cost for the clomiphene citrate in a CCCT is 
approximately $3 and the cost for the hormone injections necessary for a COS is 
approximately $1,000.  Although we as scientists strive to perform the best 
research at all times, it is not always practical to do so.  Therefore, it is important 
to understand the relative efficacy of different ORTs, along with their advantages 
and disadvantages.  It is then possible to make an informed decision with regard 
to the individual animals, housing situations and technical staff. 
 Although ORTs have been in practice in human clinics for many years 
now, this is the first study addressing their potential use in nonhuman primates.  
Proper development of ORTS in nonhuman primates can still benefit the human 
medical community with regard to the identification of reproductively comparable 
animal models to complement human research.   
 Finally, it important not to discount the value of finding and using the best 
hormone index with ORTs.  Although FSH has long been known to be an early 
marker of ovarian decline, INHB may be a more sensitive and better predictor of 
COS outcome.  The development of commercially available INHB ELISA kits has 
made it possible to easily measure INHB without the added precautions 
necessary when using radioactive isotopes (as with most FSH assays).  
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Therefore, use of INHB may be more efficacious than FSH as a diagnostic tool 
both in humans and monkeys. 
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Figure 3.1 Mean hormone levels with ORTs. Results of ovarian reserve tests 
(ORTs) for Young Control (YCON), Young CR (YCR), Old Control (OCON) and 
Old CR (OCR) with COS outcome indicated: successful COS (COS+) or 
unsuccessful COS (COS-).  A) d3 Follicle-Stimulating Hormone (FSH).  B) d3 
Inhibin B (INHB).  C) d3 and d10 FSH during Clomiphene Citrate Challenge Test 
(CCCT).  D) d3 and d10 INHB during CCCT.  E) Fold change in Estradiol (E2) 
during CCCT.  F)  Fold change in FSH during EFORT.  G) Fold change in INHB 















































































































































Figure 3.2  Day 3 Follicle-Stimulating Hormone (FSH).  A) Individual d3 FSH 
for young monkeys.  B) Individual d3 FSH for old monkeys, with retrospective 
COS+ or COS- indicated.  C)  Number correct and incorrect COS outcome 
predictions with overall percent accuracy indicated.  Day 3 FSH predictions did 





























































































































Figure 3.3  Day 3 Inhibin B (INHB).  A) Individual d3 INHB for young monkeys.  
B) Individual d3 INHB for old monkeys, with retrospective COS+ or COS- 
indicated.  C)  Number correct and incorrect COS outcome predictions with 
overall percent accuracy indicated.  Day 3 INHB predictions were marginally 















































































































































Figure 3.4 Clomiphene Citrate Challenge Test (CCCT) using Follicle-
Stimulating Hormone (FSH).  A) Individual FSH with CCCT for young monkeys 
on d3 and d10.  B) Individual FSH with CCCT for old monkeys on d3 and d10, 
with retrospective COS+ or COS- indicated.  C)  Number correct and incorrect 
COS outcome predictions with overall percent accuracy indicated.  CCCT with 

































































































































Figure 3.5 Clomiphene Citrate Challenge Test (CCCT) using Inhibin B 
(INHB).    A) Individual CCCT with INHB for young monkeys on d3 and d10.  B) 
Individual CCCT with INHB for old monkeys on d3 and d10, with retrospective 
COS+ or COS- indicated.  C)  Number correct and incorrect  COS outcome 
predictions with overall percent accuracy indicated.  CCCT with INHB predictions 



























































































































Figure 3.6 Modified Clomiphene Citrate Challenge Test (CCCT) Using 
Follicle-Stimulating Hormone (FSH) and fold change in Estradiol (E2) or 
Inhibin B (INHB) and fold change in Estradiol (E2).  A) Individual fold change 
in E2 from d3 to d10, following CCCT.  B) Number of correct and incorrect 
predictions using FSH with CCCT in conjunction with fold change in E2, including 
overall percent accuracy.  The modified CCCT with FSH predicted (p < 0.05) 
actual COS outcomes.  C) Number of correct and incorrect predictions using 
INHB with CCCT in conjunction with fold change in E2, including overall percent 














































































































Figure 3.7 Exogenous Follicle-Stimulating Hormone Ovarian Reserve Test 
(EFORT) using fold change in Estradiol (E2).  A) Individual fold change 
(increase) in E2 on d1 and d2 following EFORT.  B) Number of correct and 
incorrect predictions using fold change in E2 with EFORT, including overall 
















































































































Figure 3.8  Exogenous Follicle-Stimulating Hormone Ovarian Reserve Test 
(EFORT) using fold change in Follicle-Stimulating Hormone (FSH).  A) 
Individual fold change in FSH on d1 and d2 following EFORT.  B) Number of 
correct and incorrect predictions using fold change (decrease) in FSH with 
EFORT, including overall percent accuracy.  EFORT with FSH did not predict (p 















































































































Figure 3.9  Exogenous Follicle-Stimulating Hormone Ovarian Reserve Test 
(EFORT) using fold change in Inhibin B (INHB).  A) Individual fold change in 
INHB on d1 and d2 following EFORT.  B) Number of correct and incorrect 
predictions using fold change in INHB with EFORT, including overall percent 






Table 3.6  Outcome of controlled ovarian stimulation (COS) for young and 
old monkeys.  Young CON (YCON), young CR (YCR), old CON (OCON), old 
CR (OCR) are indicated with COS outcome: successful (COS+) or unsuccessful 
(COS-).   
ID Cohort COS  
22360 YCON + 
22362 YCON + 
22365 YCON + 
22367 YCON + 
  
22357 YCR + 
22359 YCR + 
22361 YCR + 
22364 YCR + 
  
22350 OCON + 
22351 OCON + 
22352 OCON + 
22368 OCON + 
  
22353 OCR + 
22354 OCR + 
22356 OCR + 
  
22342 OCON - 
22343 OCON - 
22345 OCON - 
22348 OCON - 
22355 OCON - 
  
22341 OCR - 












































Figure 3.10 Representative hormone profiles of a controlled ovarian 
stimulation (COS).  A) Representative estradiol (E2) profile of a successful COS 
(COS+) with accompanying ultrasound.  B) Representative E2 profile of an 
unsuccessful COS (COS-) with accompanying ultrasound. 
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Table 3.7  Summary Table of percent accuracy for selected ovarian reserve 
tests (ORTs). d3 follicle-stimulating hormone (FSH), d3 inhibin B (INHB), 
clomiphene citrate challenge test (CCCT) with and without the estradiol (E2) 
modification and the exogenous FSH ovarian reserve test (EFORT).  * indicates 
ORTs that predicted (p < 0.05) actual COS outcomes.  ** indicates ORTs that 
nearly predicted (p = 0.06) actual COS outcomes. 
  % Accuracy in Predicting COS Outcome  
  FSH INHB E2 
d3  59% 77%**   
CCCT 45% 59%   
CCCT + E2 77%* 82%*   





Figure 3.11 Flow chart for Modified CCCT Using Inhibin B.  Clomiphene 
citrate challenge test (CCCT) using inhibin B (INHB) values and fold change in 
estradiol (82% accuracy).  Day 3 INHB serves as an initial screen; values ≥ 50 
pg/mL may be excluded from further testing and predict for a successful COS 
(COS+).  If INHB < 50 pg/mL a secondary screen for fold change in E2 
determines whether COS outcome will be successful (COS+) or unsuccessful 
(COS-). 
 
d3 INHB  
≥ 50 
pg/mL 
Yes 2 fold No COS+ ↑ E2 






CALORIE RESTRICTION ENHANCES EMBRYOGENESIS 
IN THE FEMALE RHESUS MONKEY 
 
INTRODUCTION: 
The median age of menopause in women is approximately 50 years 
(Treloar, 1981); however, changes in normal hormone profiles are measurable in 
women years before clinical menopause (> 1 year without menses).  Incidence of 
aneuploidy, chromosomal abnormalities and miscarriage also increase with age.  
Furthermore, data collected form human infertility clinics suggest that aging 
occurs first in the oocytes and secondarily in the uterus (Navot et al., 1991; Navot 
et al., 1994).  Donor eggs collected from young woman may be implanted in uteri 
of older women and delivered successfully, while the reverse is not necessarily 
true.   
 Calorie restriction (CR) has been proven to increase longevity in a number 
of species, including C. elegans, D. melanogaster, rats and mice (Smith et al., 
2004).  The mechanism of action of CR is complex and appears to involve  
reduced damage incurred by free radical production via oxidative stress (Merry, 
2004).  This action of CR may provide benefits for a variety of cell types, 
including possible effect on gametes. 
Data on the effects of CR on reproduction are mixed and titration of its 
effects is necessary.  Data from rats and mice are not consistent their findings of 
CR effect on reproduction.  In mice, CR disrupted normal cycling, however 
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resumption of normal reproductive function occurred with refeeding (Nelson et 
al., 1985; Nelson et al., 1995).  Furthermore, onset of ovarian decline was 
subsequently delayed as well.  Conversely in rats, CR increased reproductive 
longevity without disrupting normal cycling (Holehan and Merry, 1985a; Merry 
and Holehan, 1985).   
 The rhesus monkey (Macaca mulatta) provides an ideal model for human 
reproductive studies in particular with regard to menopause.  Rhesus monkeys 
exhibit menstrual cycles similar to women, approximately 28 days in length 
(Heape, 1900).  The hormone profiles for estradiol (E2), progesterone (P4), 
follicle-stimulation hormone (FSH), and luteinizing hormone (LH) are also 
comparable to human cycles.  Furthermore, like humans, rhesus monkeys 
experience the periodic sloughing of the endometrial lining, resulting in 
menstruation.  This is unique to primates and thus essential in studying a true 
menopause.  Despite great interest in the applicability of CR or CR mimetics in 
humans, there has been little research evaluating its effect on the reproductive 
system in nonhuman primates.  Black and colleagues (Black et al., 2001) did not 
observe adverse effects with long-term CR in rhesus monkeys (ages 7-27 years) 
with regard to reproductive hormones measured on menstrual day 5. 
Research on the effect of short-term CR in the primate model is ongoing 
and some of the specific effects of CR on reproductive function are the focus of 
this paper.  This study is the first to evaluate the effects of CR on response to 
controlled ovarian stimulation (COS), oocyte maturation, fertilization and embryo 
development in old, peri-menopausal rhesus monkeys. 
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 MATERIALS AND METHODS 
Animals and Diet 
Rhesus monkeys (Macaca mulatta) were housed indoors, with fresh water 
ad libitum under 12L:12D lighting schedule.  Monkeys were housed at the 
Oregon National Primate Research Center (ONPRC), Oregon Health and 
Sciences University (OHSU; Beaverton, OR).  Old, peri-menopausal rhesus 
monkeys were identified for this study. 
Prior to implementation of the CR feeding regimen, monkeys were 
monitored to determine daily food intake based on ad libitum feed availability.  
The average daily value was then divided into two meals.  The CR monkey diet 
was then reduced by 10% per month until a 30% CR was achieved.  Monkeys 
were maintained on either control (CON; two meals per day) or calorie restriction 
(CR; two meal reduced by 30% per day) for 1- 2 years.  The animal groups are 
described below (Table 4.1). 
Table 4.1 Distribution of Old Peri-Menopausal Rhesus Monkeys.  Old control 
(OCON; 17-24 years) and old CR (OCR; 19-24 years) monkeys were identified 
for the study.  Monkeys were maintained on a control (CON) or a moderate 
calorie restriction (CR; 30% reduced from CON feed levels) diet for 1-2 years.        
  Age* N 
OCON 17-24 9 
OCR 19-24 7 
*Age in years at time of sampling. 
 
Blood Collection and Baseline Hormone Analyses: 
Monkeys were monitored for onset of menses (designated Menses d1).  
Serum was collected from the saphenous vein for 3 cycles (or approximately 90 
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days) following a spontaneous menses: daily during the follicular phase and 
every third day during the luteal phase.  Circulating hormones were assayed for 
estradiol (E2) and progesterone (P4) by specific electrochemoluminescent assay 
using a Roche Elecsys 2010 assay instrument at the Endocrine Services 
Laboratory Core, ONPRC (Beaverton, OR).  Luteinizing hormone (LH) was 
determined using a Leydig cell bioassay and follicle-stimulating hormone (FSH) 
was determined using an in-house radioimmunoassay (RIA).  Hormone 
concentrations were validated against previous RIAs in this laboratory (Hess et 
al., 1981; Zelinski-Wooten et al., 1995). 
E2 and P4 were retrospectively synchronized relative to the estimated 
mid-cycle LH peak (designated LH d0).  This separates the follicular and luteal 
phases and allows analyses between comparable physiological states.  Monkeys 
were assigned to one of two groups.  Mean hormone levels were calculated for 
each group (OCON or OCR).  
Inhibin B was determined using the commercially available Active Inhibin 
B kit (Diagnostic Systems Laboratory; Webster, TX).  This ELISA was validated 
for use with rhesus monkey serum in our laboratory.  Parallel displacement 
curves were obtained by comparing serially diluted (1:1 to 1:16) pooled rhesus 
monkey serum against known INHB concentrations.  Recovery of known 
concentrations of unlabeled INHB added to pooled rhesus monkey serum was 
100% with a coefficient of variation of 10%.  Inter-assay coefficients of variation 
for two internal controls were 15% and 9%.  The intra-assay coefficient of 
variation was always less than 10%.   
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Controlled Ovarian Stimulation 
In a spontaneous menstrual cycle, Antide (Ares Serono; 0.5 mg/kg BW, 
sc, at 0800h) was administered on d1-d9 to inhibit endogenous gonadotropin 
production and recombinant human FSH (r-hFSH; (Gonal-F; Ares Serono; 30 IU 
intramuscularly at 0800 and 1700)) was administered on d1-d6 followed by r-
hFSH + r-h luteinizing hormone (Lahdi; Ares Serono; im, at 0800) on d6-d9 to 
stimulate the production of multiple preovulatory follicles.  This was followed by 
an injection of h-chorionic gonadotropin (Serono; 1000 IU, im) on d10 or d11 to 
induce ovulatory maturation.   
Response to COS was determined by peak E2 levels and ultrasound 
visualization of follicles.  Monkeys were classified as Responder (R), Poor 
Responder (PR) or Non Responder (NR) based on the predetermined criteria 
(Table 4.2). 
Table 4.2 Controlled Ovarian Stimulation (COS) criteria for classifying a 
responder (R), poor responder (PR) or a non responder (NR).  Criteria for peak 
E2 and number and size of follicles described below.  
Hormone Criteria Ultrasound Criteria Outcome 
peak E2 > 1000 pg/mL > 3 follicles of 4 mm diameter / ovary R 
peak E2 < 600 pg/mL > 3 follicles of 4 mm diameter / ovary PR 
peak E2 < 600 pg/mL < 3 follicles of 4 mm diameter / ovary NR 
 
Follicle Aspiration and Embryo Culture 
Transabdominal ultrasonography, using an HDI 1000 system with a C8-5 
scanhead (ATL, Bothell, Washington) was performed on d7 to confirm the 
presence of a minimum of 3 follicles of 4mm diameter on each ovary.  Blood 
samples were also collected daily from the saphenous vein and E2 levels were 
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determined to indirectly assess follicular response.  Follicular aspiration by 
laparoscopy was performed on anesthetized animals 27 h after r-hCG injection 
(Zelinski-Wooten et al., 1995).  
 Follicular aspirates containing LGCs were pelleted and purified over a 
Percoll gradient to remove red blood cell contamination, according to techniques 
outlines by Molskness et al. (Molskness et al., 1991).  Only R and PR aspirates 
were processed, since NR monkeys did not respond to COS and were therefore 
not aspirated for LGCs or oocytes.  LGCs were counted and cell viability was 
assessed using Trypan blue exclusion.  Cells were placed on fibronectin-coated 
48-well or 96 well plates and incubated in DMEM/F12 media containing insulin, 
transferring, selenium and LDL, with or without hCG in triplicate.  Media was 
harvested after 24 hours and frozen at -20˚C until assayed for P4 and INHB.  
Triplicate values were averaged for each monkey prior to calculating group’s 
means.   
 Oocytes were recovered and evaluated for nuclear maturity at collection 
and after 6 h in vitro.  They were subsequently classified based on stage of 
nuclear maturity: presence of an intact germinal vesicle (GV), metaphase I (MI; 
absence of both a germinal vesicle and polar body), metaphase II (MII; absence 
of a germinal vesicle and presence of an extruded polar body in the perivitelline 
space) or atretic (presence of presence of fragmentation or vacuoles in ooplasm 
and/or aspherical shape). 
 The oocyte data for the young animals was unavailable; only oocytes 
collected from OCON-R and OCR-R monkeys were fertilized and monitored for 
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embryo development.  Immature (GV and MI) oocytes were allowed to incubate 
to maturity (MII) and subsequently fertilized via intracytoplasmic spermatozoa 
injection (ICSI). Mature oocytes were inseminated in vitro 6 hr after collection 
with 5 x 106 motile activated sperm (Hibbert et al., 1996; Zelinski-Wooten et al., 
1995).  Oocytes were initially classified according to the number of pronuclei 
visible on day 1 (16 h after insemination) as follows: 1) fertilized embryos (2 
pronuclei and 2 polar bodies in the perivitelline space); 2) polyspermic embryos 
(with 3 or more pronuclei); and 3) unfertilized oocytes (with ≤1 pronuclei, oocytes 
remaining as MI or MII).  On day 2, embryos were graded according to evenness 
of blastomeres, fragmentation and presence of cellular debris from perfectly 
symmetrical embryos with no fragmentation to embryos having one intact 
blastomeres with gross fragmentation or being totally degenerate (Hardy et al., 
1989).  All grading was performed by an observers who were blind to group 
identification.  In addition embryos that did not cleave into 2-cell embryos with 
normal morphology were classified as having abnormal cleavage.  Subsequently 
2- to 4-cell embryos produced by IVF were co-cultured on Buffalo Rat Liver 
(BRL) cells in CMRL-1066 culture medium containing 10% fetal calf serum; 
media was changed on alternate days.  This culture system supports 
development of IVF-produced macaque embryos to the hatched blastocyst stage 
(Weston et al., 1996; Zhang et al., 1994).  Using an Olympus inverted 
microscope embryos were charted daily for development from 4-cell to 32-cell, 
morula (M), blastocyst (B), expanded (XB) and hatched blastocyst (HB) stages or 




Data are expressed as mean ± SEM for each parameter measured in 
each group.  Standard descriptive statistics were performed.  Log transformation 
of hormones was necessary and homogeneity of variances and normality of 
residuals was tested.  Hormones were analyzed by 2-way ANOVA (repeated 
measures as necessary), followed by Tukey’s for post-hoc comparisons (SAS; 
Cary, NC) and significant differences were established at p < 0.05.   
 
RESULTS: 
Baseline Hormone Analyses 
 6 of 9 OCON (Figure 4.1A) and 5 of 7 OCR (Figure 4.1B) monkeys 
exhibited normal, cycling hormone patterns: mid-cycle E2 peak followed by 
extended luteal phase levels of P4 (> 1 ng/mL).  The remaining animals could not 
be aligned relative to the LH peak due to onset of peri-menopause and irregular 
menstrual cycles.  Cycling monkeys in both CON and CR groups show 
comparable hormone profiles.   
 
Controlled Ovarian Stimulation (COS) 
 Figure 4.2A shows the COS protocol for follicle stimulation following onset 
of menses (d1).  Figure 4.2B depicts a representative E2 profile for a responder 
during a COS and the corresponding ultrasound taken on day 7.  
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Peak E2 levels were used to indirectly evaluate ovarian response to COS.  
Mean ± standard error peak E2 levels are shown in Figure 4.3.  Responders (R) 
had significantly elevated peak E2 levels as compared to bother poor responders 
(PR) and non responders (NR).  There were no differences between CON or CR 
groups. 
 Table 4.3 shows the mean peak E2 for each R, PR and NR groups as well 
as age distributions.  The average age of OCON-PR was greater (p< 0.05) than 
that of OCON-PR.   
 
Follicle Aspiration and Embryo Culture 
 Media collected after 24 hours LGC culture with or without hCG were 
measured for P4 and INHB.  Figure 4.4A shows the mean P4 media levels in 
OCON and OCR monkeys with or without hCG.  P4 significantly increased (p< 
0.05) in hCG treated cells as compared to no hCG, however there were no diet 
effects.  Figure 4.4B shows the mean INHB media levels in OCON and OCR 
monkey with or without hCG. There was no response to hCG treatment and no 
differences between OCON or OCR. 
 Following follicle aspiration, oocytes were separated from the follicular 
fluid and counted.  There was no difference between OCON and OCR in the 
number of eggs collected (Figure 4.5A).  Figure 4.5B shows the stage of nuclear 
maturity of the collected oocytes just after aspiration.  There were no differences 
between OCON and OCR at any stage. 
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 Following ICSI, zygotes were monitored for evidence of fertilization 
(presence of 2 polar bodies).  Figure 4.6A shows the percentage of oocytes 
collected from OCON-R and OCR-R monkeys, successfully fertilized by ICSI.  
There were no differences between OCON-R and OCR-R. 
 Figure 4.7 shows the embryonic development of fertilized oocytes 
collected from OCON-R and OCR-R monkeys.  OCR-R embryos had improved 
(p<0.05) embryo development, as compared to OCON-R embryos over all 
stages.  Furthermore, only embryos from OCR oocytes developed past the 
blastocyst stage. 
 Figure 4.8 shows the rate of embryonic development in OCON and OCR.  
OCON embryos arrest at the blastocyst stage and take longer to develop than in 
OCR.  OCR embryos continue on to expanded and hatched blastocyst stages.  
 
DISCUSSION 
The calorie restriction paradigm has long been recognized as an effective 
nutritional intervention for life extension in many species (Mattison et al., 2003; 
McCay et al., 1935; Roth et al., 1999; Smith et al., 2004).  Although the effects of 
CR on extending reproductive lifespan in rodents are mixed (Holehan and Merry, 
1985c; Merry and Holehan, 1979; Nelson et al., 1985), the potential for 
developing a means for delaying menopause would be extremely beneficial.  
This study is not only the first to evaluate the effects of short-term CR in older, 
peri-menopausal rhesus monkeys and their response to follicle stimulation; but 
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also the first to demonstrate that embryonic development is actually improved in 
monkeys maintained on the CR diet.   
Although there were relatively few differences in diet with regard to 
ovarian hormone response to COS, number of oocytes retrieved and level of 
nuclear maturity, there were surprising differences between diet groups in 
embryo development in old monkeys.  Overall embryo development was better in 
OCR as compared to OCON.  Finally, and perhaps most interestingly, only 
embryos from OCR monkeys progressed beyond the blastocyst stage.  There 
were no OCON embryos observed at expanded blastocyst or hatched blastocyst 
stages.   
Careful study of the E2 and P4 dynamics within a spontaneous menstrual 
cycle established baseline hormone data.  These data corroborated previous 
findings that menstrual cycles appear normal in monkeys maintained for short-
term (1-2 years) CR diet with some irregularity expected with age.  The 
reproductive axis can be very sensitive to changes in nutrition and energy 
balance (Harber, 2000; Harber, 2004; Taylor et al., 1999; Williams et al., 2001), 
therefore it was important to ascertain that monkeys were in fact cycling with 
some normality (i.e. CR similar to CON) prior to follicle stimulation. 
 Historically, it has been believed that female vertebrates acquire 100% of 
their primordial follicles at or around the time of birth.  This doctrine has recently 
been brought into question by Johnson and colleagues (Johnson et al., 2004) 
who demonstrated that ovarian follicular renewal may be possible in mice.  
Regardless of the process, by menopause the ovary is almost completely devoid 
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of follicles.  Throughout the reproductive lifespan of any female, the number of 
follicles that become atretic is much greater than the number of follicles that 
actually proceed through to ovulation. 
 With age, the likelihood of pregnancy success, even with artificial 
reproductive technologies, is greatly reduced (Broekmans et al., 2004; 
Broekmans and Klinkert, 2004).  This brings into question the quality of oocytes 
remaining in the ovary at peri-menopause.  The technique of aspirating follicles 
following gonadotropin stimulation may result in the retrieval of atretic or “bad” 
eggs (Balmaceda et al., 1994; Lim and Tsakok, 1997; Navot et al., 1991; Serna 
and Garcia-Velasco, 2005).  Thus age and ovarian reserve are both important 
factors in evaluating response to gonadotropin treatment (Keck et al., 2005).    
We investigated the effects of CR on ovarian response to follicle 
stimulation and oocyte competence and embryogenesis in vitro in old rhesus 
monkeys.  Furthermore, we were able to monitor response to the COS both 
indirectly and directly, using peak E2 and ultrasound visualization of follicles.  It 
was interesting to note that monkeys naturally divided into three distinct groups 
(responders, poor responders and non responders).  Furthermore, within these 
groups, although there were no differences in peak E2 between OCON and 
OCR, the OCON-PRs were older than OCR-PRs.  This suggests that the CR 
treatment permitted older monkeys to continue to respond to the COS at older 
ages as compared to CON monkeys.   
COS-stimulated follicles yield mature oocytes capable of fertilization 
following insemination in vitro as well as subsequent development to pre-
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implantation embryonic stages in vitro.  The ovarian follicle is lined with 
granulosa and theca cells that respond to changes in the hormonal milieu.  
Furthermore, they are themselves hormonally active and contribute to oocyte 
development.  As expected, LGCs in both groups responded to hCG with an 
increased production of P4; however, there were no dietary differences.  
Furthermore, there was no change or difference in diet, in the levels of INHB 
produced by the LGCs in culture.  We were unable to assess granulosa cells 
prior to hCG injection and luteinization, and there may be some effects that are 
unaccounted for in this regard.  However, improved embryo development seen in 
our results can also due to effects of CR on the oocyte itself.  Clavero, et al. 
(Clavero et al., 2003) demonstrated that there was no correlation between oocyte 
maturity or fertilizability by ICSI in the percentage of apoptosis in granulosa cells 
collected by follicle stimulation.  Numerous other factors may be differentially 
regulated in CR monkeys that we have not addressed and have been shown to 
play a role in oocyte and embryo development including c-kit ligand, bone 
morphogenic proteins (BMPs), insulin like growth factor (IGF), vascular 
endothelial growth factor (VEGF), leptin or nitric oxide (Barroso et al., 1999; 
Driancourt et al., 2000; Goya et al., 2002; Hutt et al., 2006; Klein et al., 2000; 
Thomas et al., 2005). 
The large cytoplasmic contribution of the oocyte to the embryo may 
contribute to the differences we observed in embryo development with CR.  
Within the cytoplasm of the egg are mitochondrial DNA as well as a multitude of 
cytoplasmic proteins, such as cytoskeletal elements, enzymes, energy stores, 
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cell cycle regulatory proteins (Jansen and Burton, 2004; Krey et al., 2001; May-
Panloup et al., 2004).  Within human assisted reproduction, it is believed that 
abnormalities in the oocyte cytoplasm contribute to low pregnancy rates, even 
with supplemental protocols (Fulka et al., 2001; Fulka et al., 2005).  Mitochondrial 
dysfunction in the oocyte has been suggested as one of the causes of embryonic 
developmental retardation and arrest (Nagai et al., 2004).  
Although scientists are still investigating the phenomenon of life extension 
via CR, one hypothesis is that CR reduces the extent of oxidative damage 
caused by free radicals (Merry, 2004).  Mitochondrial damage may occur as a 
result of excessive reactive oxygen species and may in turn generate damage 
oxyradicals at an even greater rate.  Caspase cascades, followed by apoptosis 
are common responses to mitochondrial damage.  APAF-1 binding to free 
cytochrome c (mitochondrial protein associated with oxidative phosphorylation 
and released as a result of cellular damage) can trigger caspase aggregation and 
apoptosis.  Free radical formation is inherent to mitochondrial function and 
therefore, no system is exempt from its effects.  Therefore, reduced levels of free 
radicals, via CR, may have possible benefits to the developing oocyte (Agarwal 
et al., 2005). 
We conclude that CR may prolong ovarian responsiveness to exogenous 
gonadotropins and support oocyte nuclear maturation, fertilization and embryonic 
development in vitro in old female rhesus monkeys.  Therefore, short-term (1-2 
years) exposure to moderate CR in old female rhesus monkeys has beneficial 
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Figure 4.1 Hormone Profiles for OCON and OCR.  Graphs depict mean 
hormone profiles in a spontaneous menstrual cycle.  A) OCON (n=6), B) OCR 
(n=5) are graphed relative to the LH peak (not shown; d=0).  E2 levels are pink, 
P4 levels are blue.  E2 peaks may be observed prior to luteal levels of P4.  Blood 
samples were collected from the saphenous vein daily during the follicular phase 
and every third day during the luteal phase during a spontaneous menstrual 
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Figure 4.2. Controlled ovarian stimulation (COS) in rhesus monkeys. A) 
COS protocol: administration of Antide (to suppress endogenous hormone 
production), h-rFSH, h-rLH, hCG to induce ovulatory maturation of follicles and 
laparascopic follicle aspiration (FA).  B) Representative Responder E2 profile in 





















OCON-R OCON-PR OCON-NR OCR-R OCR-PR OCR-NR
 
Figure 4.3  Peak E2 levels in response to COS.  OCON are light blue bars, 
OCR are dark blue bars.  Mean peak E2 levels are shown for Responders 
(OCON-R, OCR-R), Poor Responders (OCON-PR, OCR-PR) and Non 
Responders (OCON-NR, OCR-NR).  Peak E2 in R monkeys was significantly 
higher (p < 0.05) than in PR or NR.  No differences were found between OCON 
or OCR in any groups. 
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Table 4.3.  Age distribution and peak E2 following COS in OCON and OCR 
monkeys.  Ages were similar for COS response in OCON-R and OCR-R as well 
as for OCON-NR and OCR-NR, however OCON-PR monkeys were significantly 
younger than OCR-PR monkeys.       
Cohort N Peak E2 Age 
OCON-R 4 1883 ± 346 20 ± 1.0 
OCON-PR 2 376 ±132 21 ± 2.0 
OCON-NR 3 386 ± 183 24 ± 0.3 
  
OCR-R 3 1710 ± 344 20 ± 0.9 
OCR-PR 2 692 ± 194 25 ± 0.5 














































Figure 4.4 Media hormone levels in LGC culture.  A) This graph depicts mean 
P4 levels in media with or without hCG.  hCG-treated cells had significantly 
higher (p<0.05) levels of P4, however no diet effects were found.  B) This graph 
shows INHB levels in LGC cultures with or without hCG.  No differences were 
found either with hCG treatment or diet.  Only OCON-R, OCON-PR, OCR-R and 
OCR-PR were included in the above analyses.  OCON-NR and OCR-NR did not 











































Figure 4.5 Number of oocytes collected and stage of nuclear maturation. 
Oocyte data were collected from OCON (R and PR) and OCR (R and PR).  A) 
This graph shows the mean number of oocytes collected via laparascopic follicle 
aspiration.  No differences were detected between OCON and OCR.  B) This 
graph shows the distribution of oocyte nuclear maturity at the time of collection.  
Nuclear maturity was assessed by: presence of a germinal vesicle (GV), absence 
of a polar body (MI), presence of a polar body (MII) or atretic.  No differences 


















Figure 4.6 Percentage of successful fertilization.  This graph shows the 
percentage of oocytes successfully fertilized (presence of 2 polar bodies) via 























Figure 4.7 Embryo development.  This graph depicts embryo development 
using in vitro culture conditions following fertilization of oocytes collected from  
OCON-R and OCR-R monkeys.  Percent embryos progressing to each of the 
following stages: 4-6 cells, 8-12 cells, 16 cells, 32 cells, morula (M), blastocyst 
(B), expanded blastocyst (XB) and hatched blastocyst (HB) were determined.  
Embryos from oocytes collected in OCR monkeys had improved (p< 0.05) 



















Figure 4.8 Rates of Embryo Development.  Embryo development rates from 
oocytes collected from old CON (OCON) and old CR (OCR) monkeys.  Stages of 
embryonic development were assessed at 4-6 cells (4-6), 8-12 cells (8-12), 16-32 
cells (16-32), morula (M), blastocyst (B), expanded blastocyst (XB) and hatched 
blastocyst (HB).  OCON embryos arrested at the blastocyst stage and took 
longer to develop in culture.  OCR embryos continued to develop to expanded 




EFFECTS OF CALORIE RESTRICTION ON RHESUS MONKEY 
GENE EXPRESSION IN LUTEINIZING GRANULOSA CELLS 
 
INTRODUCTION 
 Calorie restriction (CR) has been proven to increase longevity in a number 
of species, including C. elegans, D. melanogaster, rats, mice and limited data in 
primates (Lane et al., 1996; Lane et al., 1997; Lane et al., 2000; Le Bourg, 2005; 
Smith et al., 2004).  The mechanism of action of CR is not fully understood, 
however, researchers have demonstrated reduced damage incurred by free 
radical production via oxidative stress (Merry, 2004).   
Data on the effects of CR on reproduction are mixed and titration of level 
of CR and species response is necessary.  Data from rats and mice are 
inconsistent with regard to CR effect on reproduction.  In mice, CR disrupts 
normal cycling; however, resumption of normal reproductive function occurs with 
re-feeding (Nelson et al., 1985; Nelson et al., 1995).  Furthermore, the onset of 
ovarian decline was subsequently delayed as well.  In rats, CR has been proven 
to increase reproductive longevity without disrupting normal cycling (Holehan and 
Merry, 1985a; Merry and Holehan, 1985).  Preliminary data in rhesus monkeys 
(ages 7-27 years) suggested no adverse effects in long-term CR in rhesus 
monkeys with regard to reproductive hormones measured on menstrual day 5 
(Black et al., 2001) . 
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There has been only limited research in granulosa cell microarrays.  One 
study investigated the differences in gene expression in granulosa cells 
stimulated with or without forskolin, however these cells were collected from 
women 26-32 years, without regard for relative ovarian reserve or menstrual 
cyclicity. (Sasson et al., 2004).  Another recent study reported gene expression 
profiles in granulosa cells collected from women suffering from polycystic ovarian 
syndrome (PCOS) as compared to normal ovaries (Jansen et al., 2004). 
DNA microarray analyses of luteinizing granulosa cells by Chin et al. (Chin 
et al., 2002) demonstrated differences in gene expression between women with 
normal or decreased ovarian reserve.  Diminished ovarian reserve was 
determined based on day 3 FSH and peak serum E2 levels and number of 
oocytes retrieved following an ovarian stimulation protocol.  Chin, and colleagues 
(Chin et al., 2002) admit the difficulty in interpreting these data, given small 
sample sizes, differential responses within groups, and inconsistent gonadotropin 
stimulation of subjects.  It is still of great interest, however, to note that there 
were changes in a few specific genes.  Although inconclusive, their data provide 
a basis for identifying specific gene targets that vary within the ovary during aging 
that will be useful for future research on ovarian aging and menopause in 
women.     
 This chapter is based on preliminary findings evaluating the use of 
microarrays in evaluating gene expression changes in LGCs collected from 
young and old rhesus monkeys maintained on short-term calorie restriction. 
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MATERIALS AND METHODS 
Animals and Diet 
Young and old female rhesus monkeys were identified for this study.  
Animals were offered food and water ad libitum.  Average daily food consumption 
was determined for each monkey and divided into two meals per day.  Feed 
allotment in calorie restricted (CR) monkeys was then reduced by 10% per 
month, until 30% restriction was achieved.  Distribution of animals is indicated in 
Table 5.1. 
Table 5.1 Distribution of Animals.  Young control (YCON), young CR (YCR), 
old control (OCON) and old CR (OCR) were identified for this study.  Animal 







Controlled Ovarian Stimulation (COS) and Follicle Aspiration 
Monkeys were maintained on short-term CR for 1-2 years and monitored 
for onset of menses (d1).  A controlled ovarian stimulation (COS) was performed 
to stimulated the production of multiple pre-ovulatory follicles.  Monkeys received 
Antide (Ares Serono; 0.5 mg/kg BW, subcutaneous, at 0800h) from d1-d9.  They 
received 30 IU recombinant human follicle-stimulating hormone (r-hFSH; Gonal-
F; Ares Serono; intramuscular, twice daily) from d1-d6; followed by 30 IU r-hFSH 
+ r-h luteinizing hormone (r-hLH; Lahdi; Ares Serono; Rockland, MA); im, once 
daily) on days d7-d9.  Trans-abdominal ultrasonography was performed on day 7 
of the protocol.  When at least 3 follicles of > 4 mm diameter were visualized on 
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each ovary, r-h chorionic gonadotropin (r-hCG; Serono; Rockland, MA; 1000 IU) 
was administered the next day to mimic the LH surge and induce ovulatory 
maturation of follicles.  Follicle aspiration via laparoscopy was performed 27 h 
following the r-hCG injection.  If ultrasound follicle criteria were not met, the COS 
was canceled and no follicle aspiration was performed.  Follicle stimulation and 
aspirations were repeated once, because cell number and consequently RNA 
yield was expected to be low. 
 Peripheral blood mononuclear cells (PBMCs) collected from two unrelated 
control female rhesus monkeys were graciously donated by Dr. Janko Nikolich-
Zugich and used as a pooled reference control.   
 
RNA Extraction, Amplification and Labeling   
 Follicular aspirates were collected and oocytes were identified and 
removed from the aspirates.  The remaining aspirates containing luteinizing 
granulosa cells were pelleted and purified over a Percoll gradient to remove red 
blood cell contamination, according to techniques outlined by Molskness and 
colleagues (Molskness et al., 1991).  Cells were counted and cell viability was 
assessed using Trypan blue exclusion.  Finally cells were stored in 1 mL TRIZOL 
Reagent (Invitrogen; Carlsbad, CA) and frozen at -80۫C. 
 Luteinizing granulosa cells were extracted following the protocol outlined 
by Invitrogen for use with TRIZOL Reagent.  Briefly, cells were thawed and 
centrifuged to separate the aqueous and organic phases.  The aqueous layer 
was then processed to isolate pure RNA.  RNA concentration and quality was 
determined using an Agilent 2100 Bioanalyzer.  For monkeys with more than one 
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follicle stimulation and LGC aspiration, the sample with better quality and yield 
was chosen for microarray analysis.  RNA samples were then converted to 
cyanine5 (Cy5)- and Cy3- labeled complementary RNA (cRNA) using the Agilent 
low RNA input fluorescent linear amplification kit.  Samples were subsequently 
purified using the Agilent cRNA cleanup kit and the concentration and dye 
incorporation was determined using a Nano drop spectrophotometer.   
 
Microarrays 
 Twenty Agilent whole human genome oligo microarray kits were 
generously donated by the National Institute on Aging for this experiment.  This 
array has 44,000 60-mer oligonucleotides representing approximately 41,000 
genes and transcripts.  Rhesus monkeys have a high similarity to humans and  
we anticipated no problems using a cross-species microarray.  Cy-5 and Cy3-
labeled samples were hybridized and washed according to manufacturer’s 
recommendations.  They were then scanned using an Agilent microarray scanner 
(Model G2565BA).  The relative fluorescent intensities were determined and the 
Agilent feature extraction software was used for statistical analyses.  
Fluorescence data was then imported in JMP statistical software (Cary, NC) for 
further analysis. 
 Data were checked for normality, symmetry, range of the data and low 
standard deviation as criteria.  Principal component analyses were then 
performed, followed by replicate correlation analyses to determine if the data 
could be used as biological replicates.   
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Genes were classified based on up-regulated or down-regulated gene 
changes.  Statistical differences were noted at p < 0.05.  Gene changes were 
based on z-ratios and only changes greater than 1.5 or less than -1.5 were 
included.  Additionally, only genes with average intensities greater than 0 were 
used; this excluded high fold changes that result from intrinsically low values.  
Twelve comparisons were made between groups as follows:  gene expression 
changes (up-regulation or down-regulation) in YCON versus YCR, YCON versus 
OCON, YCR versus OCR, OCON versus OCR, YCON versus OCR, and YCR 
versus OCON.   
 
RESULTS 
Controlled Ovarian Stimulation (COS) and Follicle Aspiration 
 All young monkeys responded to COS (twice) and follicle aspirations were 
performed to collect LGCs.  Four of nine OCON and four of eight OCR 
responded to COS and were follicle aspirated at least once.    
 
RNA Extraction, Amplification and Labeling   
 All LGC samples were extracted for RNA.  A minimum of 50 ng high 
quality RNA was necessary to proceed with the amplification and labeling 
process.  All LGCs collected from young monkeys had sufficient RNA to proceed; 
therefore a single sample (from the duplicate follicle aspirations) was subjectively 
chosen for each young female.  Additionally, one YCON female and YCR female 
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had duplicate samples.  Conversely, only four of five OCON and four of five OCR 
had sufficient RNA for RNA amplification and labeling (Table 5.2). 
Table 5.2 Fluorescent-labeled cRNA for Hybridization.  Young control 
(YCON), young CR (YCR), old control (OCON) and old CR (OCR) samples 









 Data were normally distributed.  Principal component analysis and 
replication correlation analyses were performed to confirm biological replication 
within groups.   
Figure 5.1A shows the scatter plots for individual samples in the YCON 
group.  YCON samples were designated YCN1-YCN5B.  YCN5 was the selected 
female with two replicates (YCN5A and YCN5B) collected from both follicle 
aspirations.  Based on the correlation coefficients and general shape of the 
scatter plots, we determined that four of the six samples (YCN3, YCN4, YCN5A 
and YCN5B) could reliably be used as replicates in our subsequent analyses. 
Figure 5.1B shows the scatter plots for individual samples in the YCR 
group.  YCR samples were designated YCR1-YCR5B.  YCR 5 was the selected 
female with two replicates (YCR5A and YCR5B) collected from both follicle 
aspirations.  Based on the correlation coefficients and general shape of the 
scatter plots, we determined that five of the six samples (YCR1, YCR2, YCR3, 
YCR4, YCR5A) could reliably be used as replicates in our subsequent analyses. 
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Figure 5.1C shows the scatter plots for individual samples in the OCON 
group.  OCON samples were designated OCN1-OCN4.  Based on the correlation 
coefficients and general shape of the scatter plots, we determined that two of the 
four samples (OCN2 and OCN3) could reliably be used as replicates in our 
subsequent analyses. 
Figure 5.1D shows the scatter plots for individual samples in the OCR 
group.  OCON samples were designated OCR1-OCR4.  Based on the correlation 
coefficients and general shape of the scatter plots, we determined that two of the 
four samples (OCR1 and OCR2) could reliably be used as replicates in our 
subsequent analyses. 
Table 5.3 shows the final distribution of samples following the biological 
replicate analysis.  Biologically non-replicable samples were excluded from the 
analysis.   
Table 5.3 Final distribution of samples after Biological Replicate Analysis.  
Young control (YCON), young CR (YCR), old control (OCON) and old CR (OCR) 
samples included in microarray analysis.  Final animal numbers within each 







 Gene expression changes between groups were determined based on 
significance (p< 0.05), z-ratio and intensity.  The relative up- or down-regulation 
of genes for each of the twelve comparisons is summarized in Table 5.4.  Total 
gene changes as well as the subset of genes with known molecular functions are 
listed.  Specific molecular functions were identified as prospective genes for 
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future real time polymerase chain reaction (RT-PCR) analysis.  Specifically, 
apoptosis, mitochondrial, steroid or growth factor related functions were 
highlighted and listed in the following Tables.   
 Table 5.5 shows the specific gene function changes between YCON and 
YCR.  Table 5.5A lists specific genes up-regulated in YCON as compared to 
YCR.  Seven of 251 known genes were identified as potential genes of interest.  
Table 5.5B lists specific down-regulated in YCON as compared to YCR.  Three of 
87 known genes were identified as potential genes of interest.    
 Table 5.6 shows the specific gene function changes between YCON and 
YCR.  Table 5.6A lists specific genes up-regulated in YCON as compared to 
YCR.  Four of 203 known genes were identified as potential genes of interest.  
Table 5.6B lists specific down-regulated in YCON as compared to YCR.  Seven 
of 118 known genes were identified as potential genes of interest.    
 Table 5.7 shows the specific gene function changes between YCR and 
OCR.  Table 5.7A lists specific genes up-regulated in YCR as compared to OCR.  
Seven of 110 known genes were identified as potential genes of interest.  Table 
5.7B lists specific down-regulated in YCR as compared to OCR.  14 of 377 
known genes were identified as potential genes of interest.  
Table 5.8 shows the specific gene function changes between OCON and 
OCR.  Table 5.8A lists specific genes up-regulated in OCON as compared to 
OCR.  6 of 137 known genes were identified as potential genes of interest.  Table 
5.8B lists specific down-regulated in OCON as compared to OCR.  17 of 382 
known genes were identified as potential genes of interest. 
 163
Table 5.9 shows the specific gene function changes between YCON and 
OCR.  Table 5.9A lists specific genes up-regulated in YCON as compared to 
OCR.  6 of 147 known genes were identified as potential genes of interest.  Table 
5.9B lists specific down-regulated in YCON as compared to OCR.  17 of 332 
known genes were identified as potential genes of interest. 
Table 5.10 shows the specific gene function changes between YCR and 
OCON.  Table 5.10A lists specific genes up-regulated in YCR as compared to 
OCON.  5 of 158 known genes were identified as potential genes of interest.  
Table 5.10B lists specific down-regulated in YCR as compared to OCON.  6 of 
174 known genes were identified as potential genes of interest. 
 
DISCUSSION 
These are preliminary data evaluating the use of microarrays to compare 
gene expression in LGCs collected from rhesus monkeys maintained on short-
term CR.  Based on the results of the microarray, we have been able to 
recommend responsive genes to pursue and validate by real-time polymerase 
chain reaction (RT-PCR). 
 Older rhesus monkeys exhibit a reduced response to COS and poor 
follicular development, despite treatment with exogenous gonadotropins.  
Consequently, our LGC yield, RNA quantity and quality were greatly reduced in 
the older monkeys.  Once proceeding through the necessary RNA preparation 
and microarray analysis, our sample size for older monkeys had diminished 
greatly (OCON, n=2; OCR, n=2).  Similar to the publication examining gene 
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expression changes in LGCs in humans, our data will be difficult to interpret due 
to small sample sizes (Chin et al., 2002).     
  The 12 comparisons evaluated in this chapter generated 4174 gene 
changes.  Of those genes, 2476 had known molecular functions.  We subjectively 
identified a handful of molecular functions with biological relevance with regard to 
our treatments (age and CR), namely apoptosis-, mitochondrial-, hormone-, and 
transcription-related functions.  Our short-list of genes was then examined more 
carefully to further identify possibilities to pursue by RT-PCR, and is summarized 
in Table 5.11.  
Two genes with apoptotic functions were identified by our microarray 
analysis were: Homo sapiens caspase 4, apoptosis-related cysteine protease 
(CASP4) and Homo sapiens Fas apoptotic inhibitory molecule (FAIM).  These 
are potentially very interesting genes with regard to our research.  Apoptosis and 
follicular atresia occurs with regularity in growing follicles and is considered to be 
a normal physiological process (Johnson, 2000a; Tilly et al., 1992).  Conversely, 
the depletion of ovarian reserve also likely occurs via atresia and apoptosis.  
Apoptosis is a tightly regulated system in which cells undergo programmed cell 
death.  A number of pro-apoptotic proteins, Bax, Bid and Bad participate in 
programmed cell death.  In addition, caspases are proteases that split proteins at 
aspartate residues to break down cell structures and initiate a sequence of 
events that also participate in cell death. 
Interestingly delayed ovarian aging has been documented in the Bax-/- 
mouse.  Bax is a member of the Bcl-2 family of proteins which are considered to 
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be pivotal in the regulation of cell death pathways (Kim, 2005).  The Bcl-2 family 
members are generally classified as either pro-apoptotic, such as Bax, Bid and 
Bad; or anti-apoptotic, such as Bcl-2 and Bcl-XL (Kim, 2005).  Kim and 
colleagues (Kim, 2005) have hypothesized that the Bax deficiency may have 
granted some protection to the granulosa cells and oocytes against apoptosis 
and consequently delayed ovarian senescence. 
 CASP4 is known to be involved in apoptosis, particularly in endoplasmic 
reticulum stress induced apoptosis (Hitomi et al., 2004).  Our data suggest that 
CASP4 is up-regulated in OCON as compared to YCON and OCR groups.  
Furthermore, reports show that when CASP4 was restrained, apoptosis was 
arrested in sinonasal squamous carcinoma (Li et al., 2004).  
FAIM is believed to be an antagonist of Fas-induced cell death (Sole et al., 
2004).  Fas is a cell-surface receptor protein that is believe to mediates 
apoptosis-inducing signals and participates in ovarian follicular atresia (Kaipia 
and Hsueh, 1997; Manabe et al., 2004; Sakamaki et al., 1997; Slot et al., 2006).  
Results from our microarray experiment indicate that FAIM in OCR is up-
regulated as compared to YCON, YCR and OCON.  This would fit in well with our 
hypothesis that CR may be mediated some apoptotic processes in the LGCs 
collected from older monkeys. 
 Reduced damage incurred by free radical production via oxidative stress 
has been suggested as mechanism of action of CR  (Merry, 2004), therefore 
alterations in genes related to mitochondrial function may be involved in 
preserving ovarian or LGC function.  One of the genes we identified as a 
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possibility for RT-PCR is Homo sapiens uncoupling protein 3 (UCP3).  Our 
results show UCP3 to be down-regulated in OCR as compared to YCN, YCR and 
OCON.  Uncoupling proteins (UCPs) are present in the inner mitochondrial 
membrane and UCP1 at least is involved in uncoupling oxidation from 
phosphorylation during respiration and thermogenesis (Mozo et al., 2005).  UCP2 
is believed to allows for proton leakage and may be involved in reduction of free 
radical formation in neuronal tissue (Bechmann et al., 2002; Conti et al., 2005).  
The role of UCP3, however, is less clear.  Mozo and colleagues (Mozo et al., 
2006) suggest that both UCP2 and UCP3 are not involved in respiration 
uncoupling in Chinese hamster ovary cells.  Further work needs to be done both 
in understanding the role of UCP3 as confirming the changes we observed in our 
microarray experiment. 
 We also considered steroid binding as a potential molecular function of 
interest.  We found gene expression changes in Homo sapiens estrogen-related 
receptor alpha (ESRRA).  Our data suggest that ESSRA is up-regulated in OCR 
as compared to both YCON and YCR.  ESRRA is an orphan receptor that is 
believed to regulate energy metabolism in concert with peroxisome proliferator-
activated receptor gamma coactivator-1 alpha (PGC1-α) (Schreiber et al., 2004; 
Schreiber et al., 2003; Willy et al., 2004).  Furthermore, it is believed to regulate 
the expression of genes involved in oxidative phosphorylation and mitochondrial 
biogenesis and it has been suggested that ESRRA activity could be involved in 
changes that occur with the onset of metabolic disease, i.e. diabetes (Schreiber 
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et al., 2004; Willy et al., 2004).  Again, without a full understanding of the 
functions of ESSRA, it is difficult to draw conclusions. 
Finally, we identified two transcription factors of great interest: Homo 
sapiens forkhead box P1 (FOXP1) and Homo sapiens forkhead box O1A 
(FOXO1A).  Forkhead transcription factors include Foxo1, Foxo4 and Foxo6 
(Brenkman and Burgering, 2003).  Foxo transcription factors may be considered 
analogous to the DAF-16 transcription factor (and thus part of the DAF-2 
pathway) in the roundworm (C.elegans; (Kenyon et al., 1993).  This is of 
considerable interest given exciting research which has shown that loss-of-
function mutations in DAF-2 extends lifespan in the roundworm (Hosaka et al., 
2004; Kenyon, 2001).  The role of Foxo genes in mice is currently being 
explored, however it is clear that the individual genes (foxo1, foxo3a and foxo4) 
are functionally diverse (Burgering and Medema, 2003).  In vitro data suggests a 
role for Foxo genes in cell cycle arrest, apoptosis and specific stress responses 
(Castrillon et al., 2003; Tran et al., 2003). 
Of interest, is the Foxo3a-/- mouse which is a model for accelerated 
ovarian aging (Brenkman and Burgering, 2003; Castrillon et al., 2003).  These 
mice appeared outwardly normal up to 48 weeks of age, with no differences in 
body weight, or increases in cancer, or mortality.  With regard to reproduction, 
however, Castrillon et al. (Castrillon et al., 2003) reported sterility in these mice 
by 15 weeks of ages, despite normal sexual maturation (based on first litter).  
Histological analyses of ovaries indicated normal ovaries at postnatal day 3 
(PD3), but by PD8, Foxo3a-/- ovaries were consistently enlarged.  These mice 
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exhibited early follicular activation, maturation and atresia, consequently resulting 
in early depletion of ovarian reserve.  By 20 weeks, Foxo3a-/- females 
demonstrated classic signs of hypogonadotropic (elevated FSH and LH), 
hypogonadism, typical of premature ovarian failure (Castrillon et al., 2003).   
Our results show FOXP1 to be up-regulated in OCR as compared to both 
YCR and OCN.  FOXP1 is a fairly newly identified transcription factor.  It has 
been suggested as participating in macrophage differentiation (Jonsson and 
Peng, 2005) as well as a potential candidate tumor suppressor gene (Banham et 
al., 2001).  
We found FOXO1A to be down-regulated in YCON as compared to both 
OCON and OCR.  FOXO1A is believed to be involved in cell cycle regulation, 
blocking entry by regulating other proteins (Cunningham et al., 2004).  It has 
been shown to induce cycle arrest and subsequently initiate apoptosis (Bois and 
Grosveld, 2003).  Furthermore, it has been proposed as a putative tumor 
suppressor in specific cell lines (Bois et al., 2005). 
This is the first attempt to analyze rhesus monkey LGCs by microarray, in 
aged or CR animals.  Since the commencement of this study, however, a rhesus 
monkey microarray has become commercially available and may permit a more 
rigorous analysis in future studies.  Our microarray had the advantage of 
representing 40,000 genes and may be potentially more informative, as we are 
still in a “search” mode. 
Our results are preliminary, but very exciting.  Validation by RT-PCR is 
highly recommended, especially with regard to the aforementioned genes.  We 
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performed a subjective perusal of the gene changes and found many possible 
and intriguing options to pursue.  There are, however, highly sophisticated 
programs that permit a more critical and in-depth selection of genes of interest 
and may be useful to consider in the future.   
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Figure 5.1 Replicate Correlation Analysis.  Biological replicates for microarray 
analysis were determined based on shape and correlation coefficients for scatter 
plots within each group.  YCON, YCR, OCON and OCR are shown above. 
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 Table 5.4 Gene expression change comparisons.  Comparisons between 
YCON versus YCR, YCON versus OCON, YCR versus OCR, OCON versus 
OCR, YCON versus OCR, and YCR versus OCON.  e.g. There are 404 genes in 
which YCON is up-regulated as compared to YCR.  251 of the 404 identified 





Gene Changes with  
Known Function 
YCON > YCR 404 251 
YCON < YCR 147 87 
YCON > OCON 377 203 
YCON < OCON 221 118 
YCR > OCR 185 110 
YCR < OCR 627 377 
OCON > OCR 226 137 
OCON < OCR 607 382 
YCON > OCR 246 147 
YCON < OCR 507 332 
YCR > OCON 308 158 
YCR < OCON 319 174 
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Table 5.5 Gene Changes in YCON versus YCR.  Selected genes and 
molecular function for these genes A) up-regulated in YCON as compared to 
YCR or B) down-regulated in YCON as compared to YCR. 
 
A  
Gene Name Molecular Function 
Homo sapiens mitochondrial ribosomal protein S31 (MRPS31), nuclear gene 
encoding mitochondrial protein, mRNA 
DNA binding 
 
Homo sapiens transcription termination factor, mitochondrial (MTERF), nuclear 
gene encoding mitochondrial protein, mRNA 
double-stranded DNA binding 
 
Homo sapiens Chediak-Higashi syndrome 1 (CHS1), mRNA electron transporter activity 
Homo sapiens isocitrate dehydrogenase 3 (NAD+) beta (IDH3B), nuclear gene 
encoding mitochondrial protein, transcript variant 1, mRNA 
electron transporter activity 
 
Homo sapiens hypothetical protein FLJ12519 (FLJ12519), mRNA electron transporter activity 
Homo sapiens TNF receptor-associated factor 3 (TRAF3), transcript variant 1, 
mRNA 
electron transporter activity 
 
Homo sapiens IMP2 inner mitochondrial membrane protease-like (S. cerevisiae), 
mRNA (cDNA clone MGC:14829 IMAGE:4279910), complete cds 




Gene Name Molecular Function 
Homo sapiens uncoupling protein 1 (mitochondrial, proton carrier) (UCP1), 
nuclear gene encoding mitochondrial protein, mRNA 
Binding 
Homo sapiens clone 24525 mRNA sequence electron transporter activity 




Table 5.6 Gene Changes in YCON versus OCON.  Select list of gene names 
and molecular functions for genes A) up-regulated in YCON as compared to 
OCON or B) down-regulated in YCON as compared to OCON. 
 
A 
Gene Name Molecular Function 
Homo sapiens BCL2-related ovarian killer (BOK), mRNA apoptosis activator activity 
Homo sapiens interleukin 10 (IL10), mRNA apoptosis inhibitor activity 
Homo sapiens histone deacetylase 1 (HDAC1), mRNA apoptosis inhibitor activity 
Homo sapiens mitochondrial ribosomal protein L20 (MRPL20), nuclear gene 





Gene Name Molecular Function 
Homo sapiens Bcl-2 related ovarian killer (BOK) mRNA, complete cds apoptosis activator activity 
Homo sapiens mRNA; cDNA DKFZp586A181 (from clone DKFZp586A181); 
partial cds 
apoptosis regulator activity 
 
Homo sapiens DNA fragmentation factor, 40kDa, beta polypeptide (caspase-
activated DNase) (DFFB), mRNA 
apoptosis regulator activity 
 
Homo sapiens caspase 4, apoptosis-related cysteine protease (CASP4), 
transcript variant gamma, mRNA 
apoptosis regulator activity 
 
Homo sapiens putative homeodomain transcription factor 2, mRNA (cDNA clone 
IMAGE:5171332), complete cds 
electron transporter activity 
 
Homo sapiens acid fibroblast growth factor-like protein (GLIO703) mRNA, 
complete cds 
growth factor activity 
 
Homo sapiens urotensin 2 (UTS2), transcript variant 1, mRNA hormone activity 
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Table 5.7 Gene Changes in YCR versus OCR.  Select list of gene names and 
molecular functions for genes A) up-regulated in YCR as compared to OCR or B) 
down-regulated in YCR as compared to OCR. 
 
A 
Gene Name Molecular Function 
Homo sapiens baculoviral IAP repeat-containing 7 (livin) (BIRC7), transcript 
variant 2, mRNA 
apoptosis inhibitor activity 
 
Homo sapiens clone pp7122 unknown mRNA 
 
ATP-binding cassette (ABC) 
transporter activity 
Homo sapiens uncoupling protein 3 (mitochondrial, proton carrier) (UCP3), 
nuclear gene encoding mitochondrial protein, transcript variant long, mRNA 
Binding 
 
Homo sapiens solute carrier family 25 (mitochondrial carrier; phosphate carrier), 
member 24, mRNA (cDNA clone IMAGE:5753455), partial cds 
calcium ion binding 
 
Homo sapiens mRNA for FLJ00039 protein electron transporter activity 
Homo sapiens chromosome 13 open reading frame 18, mRNA (cDNA clone 
MGC:40256 IMAGE:5212065), complete cds 
electron transporter activity 
 
Homo sapiens mRNA; cDNA DKFZp686D02125 (from clone DKFZp686D02125) electron transporter activity 
 
B 
Gene Name Molecular Function 
Homo sapiens Fas apoptotic inhibitory molecule (FAIM), mRNA apoptosis inhibitor activity 
Homo sapiens myeloid cell leukemia sequence 1 (BCL2-related), transcript 
variant 1, mRNA (cDNA clone MGC:1839 IMAGE:3138465), complete cds 
apoptosis regulator activity 
 
Homo sapiens myeloid cell leukemia sequence 1 (BCL2-related) (MCL1), 
transcript variant 1, mRNA 
apoptosis regulator activity 
 
Homo sapiens solute carrier family 25, member 27 (SLC25A27), nuclear gene 
encoding mitochondrial protein, mRNA 
binding 
 
Homo sapiens mRNA for KIAA1753 protein, partial cds electron transporter activity 
Homo sapiens hypothetical protein FLJ90430, mRNA (cDNA clone MGC:26916 
IMAGE:4837196), complete cds 
electron transporter activity 
 
Homo sapiens hypothetical protein FLJ90430, mRNA (cDNA clone MGC:26916 
IMAGE:4837196), complete cds 
electron transporter activity 
 
Homo sapiens KIAA0170 mRNA, partial cds electron transporter activity 
Homo sapiens TNF receptor-associated factor 3 (TRAF3), transcript variant 1, 
mRNA 
electron transporter activity 
 
Homo sapiens vascular endothelial growth factor B (VEGFB), mRNA growth factor activity 
Homo sapiens vascular endothelial growth factor B (VEGFB), mRNA growth factor activity 
Homo sapiens IMP2 inner mitochondrial membrane protease-like (S. cerevisiae), 
mRNA (cDNA clone MGC:14829 IMAGE:4279910), complete cds 
serine-type peptidase activity 
 
Homo sapiens estrogen-related receptor alpha (ESRRA), mRNA steroid binding 
Homo sapiens forkhead box P1 (FOXP1), mRNA transcription factor activity 
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Table 5.8 Gene Changes in OCON versus OCR.  Select list of gene names and 
molecular functions for genes A) up-regulated in OCON as compared to OCR or 
B) down-regulated in OCON as compared to OCR. 
 
A 
Gene Name Molecular Function 
Homo sapiens baculoviral IAP repeat-containing 7 (livin) (BIRC7), transcript 
variant 2, mRNA 
apoptosis inhibitor activity 
 
Homo sapiens caspase 4, apoptosis-related cysteine protease (CASP4), 
transcript variant gamma, mRNA 
apoptosis regulator activity 
 
Homo sapiens CARD only protein (COP), mRNA apoptosis regulator activity 
Homo sapiens uncoupling protein 3 (mitochondrial, proton carrier) (UCP3), 
nuclear gene encoding mitochondrial protein, transcript variant long, mRNA 
binding 
 
Homo sapiens caspase 1, apoptosis-related cysteine protease (interleukin 1, 
beta, convertase) (CASP1), transcript variant alpha, mRNA 
caspase activator activity 
 
Homo sapiens translocase of outer mitochondrial membrane 7 homolog (yeast) 
(TOMM7), mRNA 




Gene Name Molecular Function 
Homo sapiens interleukin 18 (interferon-gamma-inducing factor) (IL18), mRNA apoptosis activator activity 
Homo sapiens Fas apoptotic inhibitory molecule (FAIM), mRNA apoptosis inhibitor activity 
Homo sapiens caspase 2, apoptosis-related cysteine protease (neural precursor 
cell expressed, developmentally down-regulated 2) (CASP2), transcript variant 1, 
mRNA 
apoptosis inhibitor activity 
 
 
Homo sapiens myeloid cell leukemia sequence 1 (BCL2-related), transcript 
variant 1, mRNA (cDNA clone MGC:1839 IMAGE:3138465), complete cds 
apoptosis regulator activity 
 
Homo sapiens phosphoprotein enriched in astrocytes 15 (PEA15), mRNA apoptosis regulator activity 
Homo sapiens myeloid cell leukemia sequence 1 (BCL2-related) (MCL1), 
transcript variant 1, mRNA 
apoptosis regulator activity 
 
Homo sapiens solute carrier family 25, member 27 (SLC25A27), nuclear gene 
encoding mitochondrial protein, mRNA 
binding 
 
Homo sapiens solute carrier family 25 (mitochondrial carrier; phosphate carrier), 
member 23 (SLC25A23), mRNA 
calcium ion binding 
 
Homo sapiens mRNA for KIAA1753 protein, partial cds electron transporter activity 
Homo sapiens clone 24525 mRNA sequence electron transporter activity 
Homo sapiens DKFZp434A0131 protein, mRNA (cDNA clone MGC:1130 
IMAGE:3160366), complete cds electron transporter activity 
Homo sapiens hypothetical protein FLJ90430, mRNA (cDNA clone MGC:26916 
IMAGE:4837196), complete cds 
electron transporter activity 
 
Homo sapiens hypothetical protein FLJ90430, mRNA (cDNA clone MGC:26916 
IMAGE:4837196), complete cds 
electron transporter activity 
 
Homo sapiens KIAA0170 mRNA, partial cds electron transporter activity 
Homo sapiens nuclear prelamin A recognition factor (NARF), transcript variant 1, 
mRNA 
electron transporter activity 
 
Homo sapiens estrogen-related receptor alpha (ESRRA), mRNA steroid binding 
Homo sapiens forkhead box P1 (FOXP1), mRNA transcription factor activity 
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Table 5.9 Gene changes in YCON versus OCR.  Select list of gene names and 
molecular functions for genes A) up-regulated in YCON as compared to OCR or 
B) down-regulated in YCON as compared to OCR. 
 
A 
Gene Name Molecular Function 
Homo sapiens uncoupling protein 3 (mitochondrial, proton carrier) (UCP3), 
nuclear gene encoding mitochondrial protein, transcript variant long, mRNA 
binding 
 
Homo sapiens solute carrier family 25 (mitochondrial carrier; phosphate carrier), 
member 24, mRNA (cDNA clone IMAGE:5753455), partial cds 
calcium ion binding 
 
Homo sapiens caspase 1, apoptosis-related cysteine protease (interleukin 1, 
beta, convertase) (CASP1), transcript variant alpha, mRNA 
caspase activator activity 
 
Homo sapiens mRNA for FLJ00039 protein electron transporter activity 
Homo sapiens mRNA; cDNA DKFZp686E08116 (from clone DKFZp686E08116) electron transporter activity 
Homo sapiens chromosome 13 open reading frame 18, mRNA (cDNA clone 
MGC:40256 IMAGE:5212065), complete cds 




Gene Name Molecular Function 
Homo sapiens Fas apoptotic inhibitory molecule (FAIM), mRNA apoptosis inhibitor activity 
Homo sapiens caspase 2, apoptosis-related cysteine protease (neural precursor 
cell expressed, developmentally down-regulated 2) (CASP2), transcript variant 1, 
mRNA 
apoptosis inhibitor activity 
 
 
Homo sapiens myeloid cell leukemia sequence 1 (BCL2-related), transcript 
variant 1, mRNA (cDNA clone MGC:1839 IMAGE:3138465), complete cds 
apoptosis regulator activity 
 
Homo sapiens phosphoprotein enriched in astrocytes 15 (PEA15), mRNA apoptosis regulator activity 
Homo sapiens DNA fragmentation factor, 40kDa, beta polypeptide (caspase-
activated DNase) (DFFB), mRNA 
apoptosis regulator activity 
 
Homo sapiens myeloid cell leukemia sequence 1 (BCL2-related) (MCL1), 
transcript variant 1, mRNA 
apoptosis regulator activity 
 
Homo sapiens BCL2 binding component 3 (BBC3), mRNA catalytic activity 
Homo sapiens 8-oxoguanine DNA glycosylase (OGG1), nuclear gene encoding 
mitochondrial protein, transcript variant 1b, mRNA 
damaged DNA binding 
 
Homo sapiens mRNA for KIAA1753 protein, partial cds electron transporter activity 
Homo sapiens clone 24525 mRNA sequence electron transporter activity 
Homo sapiens hypothetical protein FLJ90430, mRNA (cDNA clone MGC:26916 
IMAGE:4837196), complete cds 
electron transporter activity 
 
Homo sapiens hypothetical protein FLJ90430, mRNA (cDNA clone MGC:26916 
IMAGE:4837196), complete cds 
electron transporter activity 
 
Homo sapiens KIAA0170 mRNA, partial cds electron transporter activity 
Homo sapiens vascular endothelial growth factor B (VEGFB), mRNA growth factor activity 
Homo sapiens estrogen-related receptor alpha (ESRRA), mRNA steroid binding 
Homo sapiens forkhead box O1A (rhabdomyosarcoma) (FOXO1A), mRNA transcription factor activity 
Homo sapiens forkhead box P1 (FOXP1), mRNA transcription factor activity 
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Table 5.10 Gene Changes in YCR versus OCON.  Select list of gene names 
and molecular functions for genes A) up-regulated in YCR as compared to 
OCON or B) down-regulated in YCR as compared to OCON 
. 
A 
Gene Name Molecular Function 
Homo sapiens solute carrier family 25 (mitochondrial carrier; phosphate 
carrier), member 24, mRNA (cDNA clone IMAGE:5753455), partial cds 
calcium ion binding 
 
Homo sapiens clone 24525 mRNA sequence electron transporter activity 
Homo sapiens mRNA for FLJ00039 protein electron transporter activity 
Homo sapiens nuclear prelamin A recognition factor (NARF), transcript variant 
1, mRNA 
electron transporter activity 
 
Homo sapiens forkhead box A1 (FOXA1), mRNA transcription factor activity 
 
B 
Gene Name Molecular Function 
Homo sapiens DNA fragmentation factor, 40kDa, beta polypeptide (caspase-
activated DNase) (DFFB), mRNA 
apoptosis regulator activity 
 
Homo sapiens putative homeodomain transcription factor 2, mRNA (cDNA 
clone IMAGE:5171332), complete cds 
electron transporter activity 
 
Homo sapiens hypothetical protein FLJ12519 (FLJ12519), mRNA electron transporter activity 
Homo sapiens TNF receptor-associated factor 3 (TRAF3), transcript variant 1, 
mRNA 
electron transporter activity 
 
Homo sapiens apoptosis-related protein PNAS-1 (FLJ39616), mRNA myosin ATPase activity 
Homo sapiens mitochondrial translational initiation factor 3 (MTIF3), mRNA translation initiation factor activity 
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Table 5.11 Summary table of Gene Changes.  List of specific genes 
highlighted as possible candidates for RT-PCR. 
Gene Name Molecular Function Comparison 
Homo sapiens caspase 4, apoptosis-related cysteine 
protease (CASP4), transcript variant gamma, mRNA 
apoptosis regulator activity 
 
YCON < OCON 
OCON > OCR 
Homo sapiens Fas apoptotic inhibitory molecule 
(FAIM), mRNA 
 
apoptosis inhibitor activity 
 
 
YCR < OCR 
YCON < OCR 
OCON < OCR 
Homo sapiens uncoupling protein 3 (mitochondrial, 
proton carrier) (UCP3), nuclear gene encoding 




YCON > OCR 
YCR > OCR 
OCON > OCR 






YCON < OCR 
YCR < OCR 
OCON < OCR 
Homo sapiens forkhead box P1 (FOXP1), mRNA 
 
transcription factor activity 
 
YCR < OCR 
OCON < OCR 
Homo sapiens forkhead box O1A 
(rhabdomyosarcoma) (FOXO1A), mRNA 
transcription factor activity 
 
YCON < OCR 






The objectives of this project were to: 1) analyze general hormonal 
changes that occur with aging and peri-menopause and 2) evaluate the effects 
(whether beneficial or detrimental) of moderate (30%) CR on ovarian function 
and the age-related decline in rhesus monkeys (Macaca mulatta).  The results of 
our research are exceptionally promising and have given us insight into the use 
of the rhesus monkey model in menopause research, as well significant 
information on the normative aging processes of this animal.  Furthermore, our 
findings of improved ovarian response and embryo development after COS in 
monkeys maintained on short-term, moderate CR provide valuable data on the 
effects of CR on normal reproductive function and aging.     
The field of menopause research is still relatively new and several 
fundamental questions about menopause still remain to be answered.  For 
example, what is the first sign of reproductive decline and is it possible to 
somehow retard or delay the onset of peri-menopause?  Current models for 
studying reproductive aging include aged mouse and rat models, as well as the 
use of ovariectomized animals.  Use of the aforementioned models has 
disadvantages, not the least of which is the absence of a “true” menopause.  The 
trigger(s) for the onset of reproductive decline in women likely involves multiple 
systems and hormones.  The discovery of elevated levels of FSH and reduced 
levels of INHB in women prior to menstrual cycle irregularities provides some 
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insight into the changes that occur with declining fertility.  Unfortunately, much of 
our data on reduced fertility and hormone changes are derived from human 
fertility clinics addressing reproductive malfunction accompanying ovarian 
pathology or advanced age.     
There are few studies reporting the normal progression of ovarian decline 
in women.  Thus, validation of the rhesus monkey as an appropriate model for 
menopause is extremely beneficial both to the human and nonhuman primate 
research communities.  Insight into the normative aging processes involved in 
pre-, peri- and post-menopause will help us to understand the progression of this 
natural and inevitable life stage.  Rhesus monkeys have been widely used as an 
animal model for human reproduction, due to its similarity in menstrual cycles 
and hormone profiles (Heape, 1900).  Gilardi and colleagues’ (Gilardi et al., 
1997) paper characterizing urinary hormones during the peri-menopause brought 
into question, however, the utility of the rhesus monkey as a model for human 
menopause.  Their research suggested that one of the hallmark events of human 
menopause, namely the monotropic rise in follicle-stimulating hormone (FSH; 
(Klein et al., 1996a; Klein et al., 1996b; Klein et al., 1998; Prior, 2005), occurred 
in rhesus monkeys only after menstrual cycle irregularity was observed.  Our 
research, however, has proven that is not the case.  In fact, not only did we 
detect changes in FSH prior to menstrual cycle irregularity, but changes in inhibin 
B (INHB) were also detectable.  These data are the first to measure hormone 
profiles in older rhesus monkeys in a semi-longitudinal fashion and confirm 
parallel processes of ovarian function with entry into the peri-menopause. 
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Similar to humans, rhesus monkeys can also have varying responses to 
controlled ovarian stimulation (COS).  Menstrual cycle history alone is not 
sufficient to make predictions on the likelihood of a successful stimulation by 
exogenous gonadotropins.  Even among the regularly cycling females, we 
observed mixed responses to COS.  A single COS cycle in rhesus monkeys is 
approximately $1000 for reagents alone.  Furthermore, the cost of a failed COS 
is not only monetary; in dealing with aging females and ovarian senescence, 
timing is essential.  Therefore, the utility of developing an effective and accurate 
ovarian reserve test (ORT) in monkeys is obvious and necessary.     
The efficacy of several commonly used ORTs in human clinics proved to 
be very successful when applied in rhesus monkeys.  Prior to this report, there 
has been very little research evaluating ORTs in nonhuman primates (Marut and 
Hodgen, 1982).  Surprisingly, our results have shown that FSH is not the most 
accurate hormone measure of response to COS.  In fact, INHB was consistently 
more accurate, regardless of the ORT.  Similar to our first experiment, we found 
the CON and CR (short-term, ONPRC) responses to the ORTs to be similar. 
 Using these data on normative aging processes in rhesus monkeys we 
were further able to evaluate the effects of CR on normal reproductive function.  
Calorie restriction (CR) has long been heralded as the only proven nutritional 
intervention for life extension.  The benefits of CR were  first described in 1935 
(McCay et al., 1935) and have since been shown to be effective in a number of 
species, including roundworms, fruit flies, mice and rats (Ingram et al., 2004; 
Mattison et al., 2003; Merry, 2004; Roth et al., 1999; Smith et al., 2004).  Current 
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investigations are underway, on whether CR will extend lifespan and/or improve 
health in rhesus monkeys.   
Given the close relationship between nutrition, body fat and reproduction 
(Bray, 1997; Kiess et al., 1999; Messinis and Milingos, 1999; Misra et al., 2004), 
it was important to evaluate whether 30% CR would disrupt normal ovarian 
function.  Previous data has demonstrated that moderate extends reproductive 
lifespan in female rats (Holehan and Merry, 1985b; Merry and Holehan, 1985).  
In mice, however, extension of reproductive lifespan was only observed after re-
feeding animals; normal cycling was disrupted by the CR diet (Nelson et al., 
1985).  Our data demonstrated that moderate CR (30%) did not interfere with 
normal menstrual cycling in our rhesus monkeys.  We did not, however, find 
conclusive evidence to indicate that moderate CR had any effect (either 
beneficial or detrimental) on the onset of peri-menopause in the long-term (NIA) 
monkeys.  Menses records taken on the short-term (ONPRC) monkeys suggest 
that initiation of CR in old monkeys may not have detrimental effects within the 
first year or two on the dietary treatment; however, by year 3, there are signs of 
advancement into peri-menopause.     
    Embryo development following COS in our old CON and CR monkeys 
(short-term, ONPRC) provided surprising responses.  Oocyte quality is known to 
diminish with age (Coticchio et al., 2004; Esfandiari et al., 2005; Navot et al., 
1991; Navot et al., 1994), although the reasons for this are not fully understood.  
There are a variety of elements that may play a role in the reduction of oocyte 
quality, including external factors such as granulosa cells, follicular fluid, ovarian 
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stimulus from the pituitary; as well as internal factors such as mitochondria, 
spindle assembly and cytoplasm. 
 Our data showed similar responses between the CON and CR the number 
of oocytes collected, oocyte maturity and fertilization.  Response to the COS was 
divided into “good,” “poor,” or “non” responders.  Surprisingly, the age of poor 
responders was higher in the CON as compared to the CR group, suggesting an 
improved responsiveness to exogenous gonadotropins.  Furthermore, we found 
that embryo development was improved in oocytes collected from CR monkeys 
as compared to CON.  In fact, none of the CON embryos developed past the 
blastocyst stage, leading us to conclude that short-term exposure to moderate 
CR in old female rhesus monkeys has beneficial effects on ovarian function. 
 Finally, our preliminary findings using microarray analyses to examine 
gene expression in luteinizing granulosa cells suggest a number of exciting gene 
changes that may help to explain the mechanism of action of CR on ovarian 
function.  These include apoptotic-, mitochondrial-, and steroid binding- related 
gene functions.  These data fit in well given current hypotheses regarding 
possible mechanisms of action of CR: protection from damage by free radical 
production or gene silencing and/or activation.  
There are a number of other possible directions we can pursue based on 
the results of this work.  In particular, the long-term (NIA) CR group of monkeys 
is part of a longevity study; and as such will be monitored through to mortality.  
Unfortunately, we will be unable to take further hormone measurements in the 
short-term (ONPRC) CR group of monkeys.   
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Based on our results, we recommend a protocol for the long-term (NIA) 
group of monkeys that would continue over the course of the animals’ lifetimes 
that would require a minimum of effort for the greatest return.  Daily monitoring of 
onset of menses and continued record keeping of menstrual cycles provide a 
relatively simple and non-invasive measure of reproductive function.  Secondly, 
our data suggest that a single blood collection on menstrual cycle day 3 (onset of 
menses = day 1), measured for FSH and INHB can confer a great deal of 
information regarding the female’s reproductive status.  A second blood 
collection taken on day 21 for progesterone (P4) would confirm ovulation, 
especially necessary with aging females.  We would suggest collecting these 
samples two to three times a year during the normal breeding season 
(September through June).  Additionally, our modified clomiphene citrate 
challenge test (CCCT; day 3 blood collection for INHB and E2; 50 mg CC daily, 
on days 5-9; day 10 blood collection for estradiol) may be implemented 
subsequent to one of the scheduled blood collections at least once per year.  
Combined, these data would provide a unique longitudinal record of the ovarian 
function in aging and long-term (NIA) CR monkeys. 
 Additionally, given the intriguing embryo development data collected from 
the short-term (ONPRC) CR monkeys, it would be especially enlightening to 
perform a similar experiment in our long-term (NIA) CR colony.  By first 
performing the modified CCCT, we would be able to selectively choose those 
animals most likely to respond to COS and yield eggs via follicle aspiration.  
Since the inception of this study, a number of commercially available kits have 
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become available permitting the extraction of high quality RNA from very small 
samples.  Thus, we recommend not only collecting luteinizing granulosa cells 
(LGCs) for microarray analysis, but also oocytes (half reserved for microarray 
and half for the embryo development studies).  This will shed light on two 
questions: 1) whether long-term CR has similar effects on embryo development 
and 2) whether differential gene expression is more evident in the LGCs, or the 
oocyte itself. 
 Having the opportunity to revisit this experiment in retrospect, there are a 
few methodological points that should be considered if a repeat is possible.  A 
medical issue that was not mentioned in this thesis is the issue of incidence of 
endometriosis.  We did not anticipate the loss of females from this disease and 
as such, would recommend addition of animals at the outset of the study, 
accounting for a percentage loss from this pernicious illness.  Further studies 
investigating the effects of CR on endometriosis must also be considered.  
Secondly, without menses records taken from the long-term (NIA) females at the 
outset of the study, it is impossible to know whether some, or the entire “young” 
group of monkeys were pre- or post-pubertal when CR was initiated.  It is 
unknown whether reproductive status at CR onset would affect our results; 
however, it would at least provide a homogenous population of females.  
Furthermore, in addressing the issue of homogenous groups, it would be useful 
in the future to perform ORTs on any “old” group of monkeys.  This would allow 
investigators to separate out pre- or peri-menopausal females as it relates to 
their studies.  Finally, although rhesus monkeys have been used widely for 
 186
studies in reproduction, it would be wise to consider the use of cynomologous 
monkeys in the future.  Rhesus monkeys are seasonal breeders, even when 
housed indoors, and reproductive data cannot be collected during the summer 
months.  Alternatively, cynomologous monkeys will continue to cycle year-round 
and may be a more flexible model with similar advantages. 
There are still a number of unanswered questions left for investigators in 
this field to uncover.  To fully understand how we can delay menopause, we must 
first answer the question: how does menopause occur?  Furthermore, if in fact 
CR can delay the onset of peri-menopause, it would be of interest whether CR 
simply delays the final menses or if it changes the curve of reproductive decline 
as well.  That is, would CR also extend the period of time before the very first 
sign of declining fertility or simply change the slope of the decline? 
  A highly charged topic in menopause research, is the question of 
whether the brain or the ovary ages first?  Data suggesting that INHB levels 
begin to decline prior to elevations in FSH suggest that perhaps the first change 
occurs at the level of the ovary.  Extraction and isolation of rhesus monkey FSH 
and INHB would permit a simple experiment: hormone replacement of one or 
both of these hormones at the point when we are first able to detect differences.  
A hormone replacement regimen for women with declining fertility would be 
extremely useful. 
With the development of new methods of transplanting ovarian tissue 
(especially for use with cancer patients), it would be intriguing to test 
transplantation of ovarian tissue from control animals into CR and vice versa.  
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This may provide some useful information regarding feedback systems between 
the ovary and the hypothalamus and pituitary, especially in animals maintained 
on CR.  One of the questions that comes to mind in reviewing our embryo 
development data, is when does CR exert its effect on potentially improving 
oocyte quality?  That is, is CR affecting oocyte development from recruitment 
from the primordial follicle or at later stages: primary, secondary or tertiary 
stages?  If we could transplant a larger quantity of ovarian tissue from a CON 
into a CR monkey and subsequently administered a successful COS, would you 
see the same embryo development effects found in oocytes collected directly 
from the ovary?  And would you cancel those effects by transplanting tissue from 
a CR into a CON monkey? 
We have discussed the possibility that CR effects on mitochondrial 
function could have contributed to the benefits observed in embryo development.  
Certainly microarray analysis of oocytes collected from CON and CR monkeys 
would yield valuable data and changes in specific genes could be pursued, 
including but not limited to sirtuins, forkhead transcription factors, bcl-2 family of 
genes and of course metabolism related genes.  Additionally, since mitochondria 
are so rich in the oocyte cytoplasm, cytoplasmic transfer experiments could be 
performed.  Essentially, this involves the transfer of cytoplasmic material from 
one egg into another.  In humans, this procedure has mixed reviews, in particular 
ethical concerns regarding the transfer of mitochondrial DNA from a third party 
into the egg.  In monkeys, however, it may offer some insight into the contribution 
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of cytoplasmic mitochondria collected from CR oocytes and the effect it may 
have on CON oocytes.    
Historically, it has been believed that female vertebrates have the 
complete population of ovarian follicles at or around the time of birth.  
Furthermore, the near depletion of the follicular reserve by menopause has been 
explained by a bi-exponential loss of follicles that is greatly accelerated at 
approximately 40 years of age (vom Saal et al., 1994).  Johnson, and colleagues 
(Johnson et al., 2004) have brought that doctrine into question with recent data 
suggesting the possible de novo synthesis of oocytes and follicles in adult mice.  
There is also controversy regarding the accurate measurement of ovarian 
follicles and whether the bi-exponential loss of follicles is a true measure of 
follicular depletion.  Thus, two questions come to mind, including what exactly 
are the morphometric follicular changes occurring in the ovary at peri-menopause 
and does CR affect those changes?  Additionally, if in fact Johnson and 
colleagues are correct in their report that de novo oocyte synthesis is possible, is 
CR acting by re-populating the follicular reserves, rather than by maintaining 
them?  Identification of a gene that can “jump-start” oocyte and follicular 
production would be worth its weight in gold for women who have found 
themselves in infertility clinics at 35 years age.  
It would also be wonderful to systematically ovariectomize rhesus 
monkeys at specific reproductive life stages: birth, pre- and post-pubertal, pre-, 
peri- and post-menopausal.  We could identify the appropriate monkeys at each 
menopausal stage by using menses records, day 3 INHB and/or the modified 
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CCCT.  In this way, we could capture snapshot records of ovarian morphology 
and follicular populations (including data on primordial, primary, secondary 
follicles, etc).   Performing this same experiment using both CON and CR would 
help to uncover how CR is affecting ovarian health and aging.  Perhaps it would 
be even more useful to perform this experiment first on mice and rats; this may 
assist in elucidating the differences found between these two species with regard 
to continued or disrupted cycling with implementation of CR. 
We do not yet know whether moderate CR will delay menopause in the 
long-term (NIA) monkeys.  Rodent data are mixed with regard to ovarian 
response to CR.  Perhaps rhesus monkeys will be more “rat”-like and 
demonstrate delayed reproductive aging.  Conversely, rhesus monkeys may be 
more “mouse”-like and require menstrual cycle disruption to elicit the same 
response.  It would be interesting to initiate CR levels high enough to disrupt 
normal menstrual cycling.  Long-term acyclicity, followed by re-feeding may show 
more dramatic results in rhesus monkeys than long-term maintenance on 
moderate CR.  If results indicated that long-term acyclicity did improve or 
maintain reproductive function with re-feeding, it may be more practical to 
consider the use of long-term gonadotropin releasing hormone (GnRH) 
antagonists.  Limited data have been published suggesting the efficacy of 
ovarian suppression in ovo-protection during chemotherapy.  Perhaps CR effects 
on extending reproductive lifespan in mice works via a similar mechanism. 
In keeping with our findings that suggest improved embryo quality in 
monkeys maintained on CR, it would be extremely useful to also perform 
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fluorescent in situ hybridization (FISH) identification on chromosomes in the 
oocytes collected following COS.  Aneuploidy and trisomy increases with age of 
conception in women; thus analysis of oocytes collected from CON and CR 
monkeys would further elucidate questions about egg quality and possible 
chromosomal abnormalities in these monkeys.      
 The prospect of delaying menopause has wider reaching impact than 
simply extending reproductive lifespan.  A number of menopause-related 
diseases are major health issues for women over 50, including cardiovascular, 
cognitive, skeletal issues (Gosden, 1985; Nappi et al., 1999; Prior, 1998; 
Sherwin, 2003).  Thus, further understanding of CR and its effect on ovarian 
function is timely and relevant.  Although implementing moderate CR in women 
would be a difficult lifestyle change, in the short-term it may be feasible.  
Furthermore, the development of CR mimetics is currently underway and may be 
a useful means of acquiring the benefits of CR without the dietary regimen.  We 
hope that this research may serve as a foundation and launching point for future 
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